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1. INTRODUCTION 
1.1. Principles of Wound Healing 
Wound healing is the physiological body’s response to damage in order to restore, i.e. to 
regenerate, both the structure and the function of an injured tissue, a diseased organ or a missing 
part of the body. In all animals, regenerative mechanisms occur following the injury but their 
efficiency is dramatically variable depending on the biological complexity. In fact, the lower 
animals have an extraordinary regenerative potential while the higher ones preserve a limited 
potential. For example, Hydra lets any isolated fragments of body or aggregates of dissociated cells 
regenerate a complete and viable organism. There are evidences that the regeneration process in 
Hydra occurs almost exclusively by morphallaxis, i.e. the transformation of existing tissues into 
newly organized structures (Bosch, 2007). Analogously, the freshwater planarians can regenerate an 
entire body from almost any body piece after cutting. In a different way from Hydra model, the 
regeneration in planarian occurs by proliferation of undifferentiated cells producing a new tissue 
called blastema, which will grow and differentiate to replace the most distal structures lost when the 
organism has been cut. The remaining part of the old tissue readapts to the new one by cell death, 
proliferation and differentiation (Salo et al., 2009). In addition to phylogenetic development, the 
regenerative potential also depends on ontogenetic development of the organism. In particular, the 
newt has the ability to repeatedly regenerate its limbs independently of its age, while other 
amphibians such as axolotl, which can regenerate limbs in the larval stage, deteriorate or lose such 
ability after metamorphosis (Tanaka et al., 2016). In mammals, the regenerative capacity is limited 
and the rapid repair of the injury by deposition of fibrotic tissue often prevents the tissue 
regeneration, especially when the injury is extended. In after-birth humans, the amputated digit tips 
can regrow revealing a nearly perfect healing of nail bed, bone, and subcutaneous tissue, when the 
loss occurs in the first decade of life and before sexual maturity (Kisch et al., 2015). In the adult 
humans, any epithelia, bones, liver and the hematopoietic system represent tissues with the highest 
regenerative capacity (Eming et al., 2014). In general, such differences in the regenerative potential 
of humans throughout their lifespan could be explained referring to the content of undifferentiated 
cells within tissues, which are more abundant in the foetal and neonatal life than in adults 
(Cancedda et al., 2017). In any way, the rapid response to a severe damage by fibrotic repair could 
represent a survival advantage because it prevents lethal infections, stops quickly the bleeding and 
inhibits the mechanical deformation of tissues (Gurtner et al., 2008). Moreover, the complete 
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regeneration of extended portions of tissues or parts of body would be energetically unsustainable 
for a complex organism. 
1.2. Molecular Mechanisms of Wound Healing 
The classical model of wound healing is composed of three distinct but overlapping phases: i) 
inflammation, ii) new tissue formation, iii) remodelling. In all tissues, apart from hyaline cartilage, 
the first phase starts immediately after the damage by haemostasis in order to stop the blood 
extravasation. Haemostasis is initially achieved by vasoconstriction, then with the formation of a 
platelet plug and finally with the activation of coagulation cascade and the formation of a fibrin 
clot. When platelets encounter exposed collagen and von Willebrand factor in the sub-endothelial 
layer of a damaged vessel and remain entrapped in the fibrin clot, they activate and release a 
cocktail of more than 300 bioactive soluble molecules in the surrounding microenvironment by 
degranulation triggering the real healing process (Golebiewska and Poole, 2015). In particular, 
platelet-derived molecules together with microbial components and the activation of complement 
regulate the migration of innate myeloid-lineage cells from nearby tissues and from the circulation. 
Neutrophils are the first inflammatory cells recruited after the tissue damage and clean the wound 
site from pathogenic microorganisms and apoptotic cells. The recruitment of neutrophils is initially 
induced by damage-associated molecular patterns (DAMPs), released at the injury site, and then by 
CXC-chemokine ligand 8 (CXCL8) family chemokines and leukotrienes, released from surrounding 
tissue cells. Early-arriving neutrophils are then themselves activated to both directly and indirectly 
promote further secretion of CXCL8 family chemokines and leukotriene B4 (LTB4) inducing 
neutrophil recruitment from the circulation and amplification of the response (de Oliveira et al., 
2016). Macrophages, derived mainly from monocytes of peripheral blood, arrive a little later and 
clear the wound of all matrix and cell debris, including fibrin and apoptotic neutrophils by 
phagocytosis. In response to various stimuli, monocytes/macrophages undergo a reprogramming 
which leads to the emergence of a spectrum of distinct functional phenotypes: the classically 
activated M1 phenotype, induced by IFNγ alone or in concert with microbial stimuli (e.g. LPS) or 
cytokines (e.g. GM-CSF), the alternatively activated M2 phenotype, induced by cytokines such as 
IL-4 and IL-13, and the “M2-like” phenotype, which shares some but not all signature features of 
M2 cells. In general, M1 cells are efﬁcient producers of effector molecules (reactive oxygen and 
nitrogen intermediates) and inﬂammatory cytokines (IL-1β, TNF, IL-6), participate as inducer and 
effector cells in polarized Th1 responses and mediate resistance against intracellular parasites and 
tumours. Instead, M2 cells take part in polarized Th2 responses, parasite clearance, the dampening 
of inﬂammation, the promotion of tissue remodelling, angiogenesis, tumour progression and 
immunoregulation (Mantovani et al., 2013). Mast cells, derived from circulating basophils, are 
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recruited with a somewhat later time course respect to neutrophils and macrophages and have been 
postulated to act during the later post-inflammatory phases of the healing process (Martin and 
Leibovich, 2005). Each of these inflammatory cell types releases cocktails of growth factors and 
cytokines that regulate the progression of the physiological response to injury. At the wound site, an 
inflammatory microenvironment is hence established that mobilizes or recruits local and circulating 
endothelial cells, stem/progenitor cells and other cells with healing potential (Cancedda et al., 
2017). The second phase of wound healing is characterized by the differentiation of fibroblasts into 
myofibroblasts and the formation of new blood vessels from the pre-existing vasculature. 
Myofibroblasts are contractile cells, with stress fibres containing α-smooth muscle actin, that move 
the edges of the wound close and also deposit collagen and other components of the extracellular 
matrix (ECM) (Darby et al., 2014). During the wound closure process, biomechanical forces 
elicited by myofibroblasts induce looping and splitting angiogenesis, which are processes of 
angiogenesis faster than sprouting occurring during the early embryonic development (Kreuger and 
Phillipson, 2015). Simultaneously, the reprogramming of resident differentiated cells and the 
recruitment of stem/progenitor cells out from their niche lead them to proliferate and reconstitute 
the missing parts of the damaged tissue. In the remodelling phase, collagen is remodelled and 
realigned along tension lines and apoptosis removes unnecessary cells (Atala et al., 2010).  
When the tissue injury is severe or repetitive or if the wound-healing response itself becomes 
dysregulated, a progressively irreversible fibrotic response occurs at the expense of tissue 
regeneration. The outcome of fibrosis is the formation of a pathological tissue, known as scar tissue, 
showing an aberrant structure characterized by few cells, mainly fibroblasts, embedded in 
excessively collagen-rich ECM, which prevents the repaired tissue recovering its original function. 
In this scenario, ECM-secreting myofibroblasts are central to the pathogenesis of all fibrotic 
diseases but it is not completely clear which molecular and immunological mechanisms induce the 
uncontrolled differentiation of quiescent fibroblasts into actively proliferating ECM-producing 
myofibroblasts (Wynn and Ramalingam, 2012). Some evidences show that a prolonged disturbance 
in the coagulation cascade can lead to fibrosis and deficiencies in the clotting pathway can also 
contribute to it. Moreover, acute inflammatory reactions play an important part in triggering 
fibrosis. In fact, if the inflammatory macrophages and neutrophils are not quickly eliminated, they 
can exacerbate the inflammatory response that leads to scarring (Wynn and Ramalingam, 2012). 
1.3. Regenerative Medicine: Classical and Innovative Approaches 
The mission of regenerative medicine is to envisage and provide next-generation therapeutic 
solutions to physicians against wound-healing-related diseases, in which the wound-healing process 
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is poor or impaired, or against critical-size injuries. In this context, patients affected by visual and 
hearing impairments, difficult-to-heal large tissue defects, chronic skin wounds, or fibrotic diseases 
represent examples of target for the regenerative medicine.  
Historically, the first successful experience of regenerative medicine is represented by the 
therapeutic application of autologous cultured human epithelium in two children who sustained 
burns on more than 95% of their bodies (Gallico et al., 1984). That approach based on the ex vivo 
expansion of autologous stem/progenitor cells before their use on the patient is commonly named 
“Cell Therapy”. Another approach, indicated as “Tissue Engineering”, uses biomaterials combined 
or not with expanded cells and biologically active molecules to recreate a functional tissue. 
In this field, the Regenerative Medicine Lab of IRCCS Ospedale Policlinico San Martino at Genova 
(Italy) was among the pioneers all over the world and the major results were about the use of 
autologous and allogenic cultured human epidermal cells in the treatment of partial and full skin 
thickness burns (De Luca et al., 1989), the use of autologous graft of cultured urethral epithelium 
for the treatment of posterior hypospadias (Romagnoli et al., 1990), the restoration of the human 
corneal surface with autologous corneal epithelial sheets (Pellegrini et al., 1997) and the 
reconstruction of large bone segments with the use of autologous bone marrow stromal cells 
(Quarto et al., 2001). Although the successful outcomes of these experimental therapies and others 
reported in literature, a very few number of them reached the status of Advanced Therapy 
Medicinal Products (ATMPs), i.e. those “medicines for human use that are based on genes or cells” 
(http://www.ema.europa.eu/ema/). In the European Union, only four ATMPs with orphan 
designation (Glybera, Strimvelis, Zalmoxis, and Holoclar) have obtained the marketing 
authorisation by the European Medicines Agency (EMA) and a ten-year market exclusivity (Farkas 
et al., 2017). The major constraints for the broad use of these experimental therapies are the high 
costs of ex vivo cell manipulation in GMP (Good Manufacturing Practice)-qualified structures and 
the complexity/morbidity of surgical procedures (Cancedda et al., 2017).  
The new frontier of regenerative medicine heads towards approaches able to modulate the scar 
response and reactive and enhance dormant endogenous regenerative mechanisms since the 
molecular regeneration regulators are conserved in mammals, including humans. This prospect 
appears very encouraging because it would allow to practise a personalized medicine and to 
develop less invasive therapeutic treatments potentially administered at home. However, classical 
strategies (tissue engineering and cell therapy) remain the best solution in extreme and very critical 
situations, such as skin burns or critical-size bone defects. In this innovative prospect, platelet by-
products represent promising clinical tools because they are based on that well-balanced cocktail of 
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bioactive molecules physiologically released by activated platelets at the wound site. The use of 
autologous Platelet Rich Plasma (PRP) for the treatment of soft and hard tissue lesions is the most 
representative example of clinical application of this approach. Although PRP is broadly used in the 
clinical practise for the treatment of knee and hip osteoarthritis (Laver et al., 2017) and tendon and 
ligament injuries (Yuan et al., 2013) or in aesthetic (Frautschi et al., 2016), oral and maxillofacial 
surgery (Mihaylova et al., 2017), the outcomes reported in the literature about its efficacy are 
controversial especially because of the un-standardized preparation of PRP and variability of the 
current PRP treatment protocols. The PRP was also proposed as a tool for enhancing the healing of 
chronic wounds even if there are in literature some contradictory outcomes considering the 
aetiologies of wounds, (Martinez-Zapata et al., 2012) (Suryanarayan et al., 2013) (Suthar et al., 
2017).  
1.4. Aim of the Ph.D. Project 
The new therapeutic approaches for the treatment of chronic wounds are based on in situ 
administration of bioactive molecules, incorporated or not in natural/synthetic dressings (Eming et 
al., 2014). In this field, the platelet derivatives have a strong potentiality because of their 
composition and beneficial effects. Starting from this preliminary consideration, my group of 
research has taken an interest in those endogenous regenerative mechanisms activated by platelet-
derived factors during the healing of injured skin in order to provide a rationale for clinical use of 
platelet derivatives for the treatment of chronic wounds. In particular, they have previously reported 
that platelet lysate enhanced wound closure rates of human keratinocytes in association with a high 
expression of the inflammatory cytokine IL-8 and of the antimicrobial lipocalin NGAL,	 through a 
pathway involving both p38 MAPK and NF-κB, under inflammatory conditions. These preliminary 
data suggest that platelet lysate possibly promotes wound healing by the induction of re-
epithelialization and the enhancement of inflammatory response at wound site that leads to 
secretion of factors involved in healing and in warding off bacterial infection (El Backly et al., 
2011).  
Starting from these encouraging findings, I focused my attention during my Ph.D. period on two 
different cell systems – endothelial and adipose stromal cells – physiologically involved in skin 
healing evaluating their response to platelet-derived factors under conditions mimicking as much as 
possible the wound microenvironment in order to mainly clarify the regenerative pathways possibly 
participating to the healing of chronic wounds.    
In the first study, I analysed the effect exerted by platelet lysate (PL) on the inflammatory, 
proliferative and angiogenesis-related response of primary human umbilical vein endothelial cells 
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(HUVECs) since endothelial cells are the first cell population responding to platelet-derived factors. 
Considering that injured blood vessel repair and re-establishment of blood circulation are crucial for 
tissue repair, the goal of this study was to elucidate the contribution of resident endothelial cells to 
new vessel formation since the mechanisms of angiogenesis are not currently well defined. 
In the second study, I focused my attention on human subcutaneous adipose tissue to examine its 
role in supporting the repair process of skin wounds since this tissue is located beneath the skin and 
physiologically contribute to re-establish the homeostasis of the damaged skin. Starting from this 
consideration, I defined a clinically relevant model for studying the in vitro response of 
subcutaneous adipose tissue to an injury. In particular, I used some early injury-associated stimuli, 
which were human serum (HS), platelet lysate (PL) and interleukin-1α (IL-1α), for mimicking as 
much as possible in situ wound microenvironment. These stimuli were tested separately or 
combining them on primary human adipose-derived stromal cells (hASCs) with the aim of 
investigating their proliferative and differentiation capabilities and their inflammation-related 
secretory activity. To reduce the gap between the results obtained in in vitro experiments and the 
regenerative mechanisms possibly activated in vivo following the injury, I decided to test the same 
stimuli on in toto human adipose tissue (hATs) cultured ex vivo.  
Both these studies were conceived for identifying those pathways need to be activated and those 
ones to be limited for the healing of injured skin and for providing, hence, a rationale for the 
therapeutic treatment of chronic wounds by using platelet derivatives.  
1.5. References – Chapter 1 
Atala, A., Irvine, D. J., Moses, M., and Shaunak, S. (2010). Wound Healing Versus Regeneration: 
Role of the Tissue Environment in Regenerative Medicine. MRS Bull. 35, 597–606. 
doi:10.1557/mrs2010.528. 
Bosch, T. C. G. (2007). Why polyps regenerate and we don’t: Towards a cellular and molecular 
framework for Hydra regeneration. Dev. Biol. 303, 421–433. doi:10.1016/j.ydbio.2006.12.012. 
Cancedda, R., Bollini, S., Descalzi, F., Mastrogiacomo, M., and Tasso, R. (2017). Learning from 
Mother Nature: Innovative Tools to Boost Endogenous Repair of Critical or Difficult-to-Heal 
Large Tissue Defects. Front. Bioeng. Biotechnol. 5, 1–13. doi:10.3389/fbioe.2017.00028. 
Darby, I. A., Laverdet, B., Bonté, F., and Desmouliere, A. (2014). Fibroblasts and myofibroblasts in 
wound healing. Clin. Cosmet. Investig. Dermatol., 301. doi:10.2147/CCID.S50046. 
De Luca, M., Albanese, E., Bondanza, S., Megna, M., Ugozzoli, L., Molina, F., et al. (1989). 
Multicentre experience in the treatment of burns with autologous and allogenic cultured 
epithelium, fresh or preserved in a frozen state. Burns 15, 303–9. Available at: 
	 11 
http://www.ncbi.nlm.nih.gov/pubmed/2686683. 
de Oliveira, S., Rosowski, E. E., and Huttenlocher, A. (2016). Neutrophil migration in infection and 
wound repair: going forward in reverse. Nat. Rev. Immunol. 16, 378–391. 
doi:10.1038/nri.2016.49. 
El Backly, R., Ulivi, V., Ph, D., Tonachini, L., Ph, D., Mastrogiacomo, M., et al. (2011). Platelet 
Lysate Induces In Vitro Wound Healing of Human Keratinocytes Associated with a Strong 
Proinflammatory Response. 17. doi:10.1089/ten.tea.2010.0729. 
Eming, S. A., Martin, P., and Tomic-Canic, M. (2014). Wound repair and regeneration: 
mechanisms, signaling, and translation. Sci. Transl. Med. 6, 265sr6. 
doi:10.1126/scitranslmed.3009337. 
Farkas, A. M., Mariz, S., Stoyanova-Beninska, V., Celis, P., Vamvakas, S., Larsson, K., et al. 
(2017). Advanced Therapy Medicinal Products for Rare Diseases: State of Play of Incentives 
Supporting Development in Europe. Front. Med. 4. doi:10.3389/fmed.2017.00053. 
Frautschi, R. S., Hashem, A. M., Halasa, B., Cakmakoglu, C., and Zins, J. E. (2016). Current 
Evidence for Clinical Efficacy of Platelet Rich Plasma in Aesthetic Surgery: A Systematic 
Review. Aesthetic Surg. J., sjw178. doi:10.1093/asj/sjw178. 
Gallico, G. G., O’Connor, N. E., Compton, C. C., Kehinde, O., and Green, H. (1984). Permanent 
Coverage of Large Burn Wounds with Autologous Cultured Human Epithelium. N. Engl. J. 
Med. 311, 448–451. doi:10.1056/NEJM198408163110706. 
Golebiewska, E. M., and Poole, A. W. (2015). Platelet secretion : From haemostasis to wound 
healing and beyond. YBLRE 29, 153–162. doi:10.1016/j.blre.2014.10.003. 
Gurtner, G. C., Werner, S., Barrandon, Y., and Longaker, M. T. (2008). Wound repair and 
regeneration. Nature 453, 314–21. doi:10.1038/nature07039. 
Kisch, T., Klemens, J. M., Hofmann, K., Liodaki, E., Gierloff, M., Moellmeier, D., et al. (2015). 
Collection of Wound Exudate From Human Digit Tip Amputations Does Not Impair 
Regenerative Healing. Medicine (Baltimore). 94, e1764. doi:10.1097/MD.0000000000001764. 
Kreuger, J., and Phillipson, M. (2015). Targeting vascular and leukocyte communication in 
angiogenesis, inflammation and fibrosis. Nat. Rev. Drug Discov. 15, 125–142. 
doi:10.1038/nrd.2015.2. 
Laver, L., Marom, N., Dnyanesh, L., Mei-Dan, O., Espregueira-Mendes, J., and Gobbi, A. (2017). 
PRP for Degenerative Cartilage Disease: A Systematic Review of Clinical Studies. Cartilage 
8, 341–364. doi:10.1177/1947603516670709. 
Mantovani, A., Biswas, S. K., Galdiero, M. R., Sica, A., and Locati, M. (2013). Macrophage 
plasticity and polarization in tissue repair and remodelling. J. Pathol. 229, 176–185. 
	 12 
doi:10.1002/path.4133. 
Martin, P., and Leibovich, S. J. (2005). Inflammatory cells during wound repair: the good, the bad 
and the ugly. Trends Cell Biol. 15, 599–607. doi:10.1016/j.tcb.2005.09.002. 
Martinez-Zapata, M. J., Martí-Carvajal, A. J., Solà, I., Expósito, J. A., Bolíbar, I., Rodríguez, L., et 
al. (2012). Autologous platelet-rich plasma for treating chronic wounds. Cochrane Database 
Syst. Rev. 10, CD006899. doi:10.1002/14651858.CD006899.pub2. 
Mihaylova, Z., Mitev, V., Stanimirov, P., Isaeva, A., Gateva, N., and Ishkitiev, N. (2017). Use of 
platelet concentrates in oral and maxillofacial surgery: an overview. Acta Odontol. Scand. 75, 
1–11. doi:10.1080/00016357.2016.1236985. 
Pellegrini, G., Traverso, C. E., Franzi, A. T., Zingirian, M., Cancedda, R., and De Luca, M. (1997). 
Long-term restoration of damaged corneal surfaces with autologous cultivated corneal 
epithelium. Lancet 349, 990–993. doi:10.1016/S0140-6736(96)11188-0. 
Quarto, R., Mastrogiacomo, M., Cancedda, R., Kutepov, S. M., Mukhachev, V., Lavroukov, A., et 
al. (2001). Repair of large bone defects with the use of autologous bone marrow stromal cells. 
N. Engl. J. Med. 344, 385–6. doi:10.1056/NEJM200102013440516. 
Romagnoli, G., De Luca, M., Faranda, F., Bandelloni, R., Franzi, A. T., Cataliotti, F., et al. (1990). 
Treatment of Posterior Hypospadias by the Autologous Graft of Cultured Urethral Epithelium. 
N. Engl. J. Med. 323, 527–530. doi:10.1056/NEJM199008233230806. 
Salo, E., Abril, J. F., Adell, T., Cebria, F., Eckelt, K., Fernandez-Taboada, E., et al. (2009). 
Planarian regeneration: achievements and future directions after 20 years of research. Int. J. 
Dev. Biol. 53, 1317–1327. doi:10.1387/ijdb.072414es. 
Suryanarayan, S., Budamakuntala, L., Suresh, D., and Sarvajnamurthy, S. (2013). Autologous 
platelet rich plasma in chronic venous ulcers: Study of 17 cases. J. Cutan. Aesthet. Surg. 6, 97. 
doi:10.4103/0974-2077.112671. 
Suthar, M., Gupta, S., Bukhari, S., and Ponemone, V. (2017). Treatment of chronic non-healing 
ulcers using autologous platelet rich plasma: a case series. J. Biomed. Sci. 24, 16. 
doi:10.1186/s12929-017-0324-1. 
Tanaka, H. V., Ng, N. C. Y., Yang Yu, Z., Casco-Robles, M. M., Maruo, F., Tsonis, P. A., et al. 
(2016). A developmentally regulated switch from stem cells to dedifferentiation for limb 
muscle regeneration in newts. Nat. Commun. 7, 11069. doi:10.1038/ncomms11069. 
Wynn, T. A., and Ramalingam, T. R. (2012). Mechanisms of fibrosis: therapeutic translation for 
fibrotic disease. Nat. Med. 18, 1028–1040. doi:10.1038/nm.2807. 
Yuan, T., Zhang, C.-Q., and Wang, J. H.-C. (2013). Augmenting tendon and ligament repair with 
platelet-rich plasma (PRP). Muscles. Ligaments Tendons J. 3, 139–49. 
	 13 
doi:10.11138/mltj/2013.3.3.139. 
 
	 14 
2. PLATELET LYSATE EFFECT ON HUMAN UMBILICAL VEIN ENDOTHELIAL 
CELLS: INHIBITION OF ACTIVATED NF-κB, INDUCTION OF PROLIFERATION 
AND ACTIVATION OF ANGIOGENESIS-RELATED STAT3 AND HIF-1α – 
SUBMITTED PAPER 
 
 
Alessio Romaldini1*, Valentina Ulivi1*, Maddalena Mastrogiacomo1, Ranieri Cancedda1,2, and 
Fiorella Descalzi2 
 
1 Department of Experimental Medicine, University of Genova, Genova, Italy;  
2 Biorigen Srl, Genova, Italy;  
 
* These authors contributed equally to the paper 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
	 15 
2.1. Abstract 
Injured blood vessel repair and blood circulation re-establishment are crucial events for tissue 
repair. In this study, we investigated the effects of platelet lysate (PL) on primary human umbilical 
vein endothelial cells (HUVECs) in order to elucidate the contribution of molecules contained in 
isolated platelets on the activation of endothelial cells in an in vitro system. The PL is a well-
balanced cocktail of bioactive factors possibly representing the factors physiologically released by 
activated platelets following blood vessel disruption and involved in triggering wound-healing 
process. We found that PL exerted a protective effect on HUVECs in inflammatory milieu by 
inhibiting IL-1α-activated NF-κB pathway and by inducing the secretion of PGE2, described as a 
pro-resolving factor towards macrophages in the wound microenvironment. Moreover, PL 
enhanced the proliferation of HUVECs, without affecting their capability of forming tube-like 
structures on matrigel, and activated resting quiescent cells to re-enter cell cycle and proliferate 
reaching a cell density significantly higher than the un-stimulated cells. In agreement with these 
findings, proliferation-related pathways Akt and ERKs were activated as well as the expression of 
the cell-cycle activator Cyclin D1 was enhanced demonstrating that quiescent cells, at a stage of 
basic metabolism, were activated by PL and resumed proliferation possibly contributing to vessel 
restoration. Finally, PL induced in HUVECs the stabilization of HIF-1α and the phosphorylation of 
STAT3, which are involved in the angiogenesis, suggesting the possible in vivo contribution of PL 
to new vessel formation by activation of resident progenitor cells located in the vessel walls. Our 
findings provide a rationale for the clinical use of PL in the treatment of wound healing-related 
pathologies. 
2.2. Introduction 
The wound healing is the physiological response of the body to injury or disease in order to restore 
tissue or organ integrity and homeostasis. Adult mammals, including humans, have a limited 
regenerative potential and tend to repair wounds by fibrosis and scarring. Scarring is the result of a 
prolonged or chronic inflammatory response. Therefore, an early inflammatory response represents 
the critical point for a successful regeneration process (Atala et al., 2010). The scar tissue is 
characterized by an aberrant structure, which prevents the repaired tissue from recovering its 
original function. A fibrotic repair may determine a complex medical case with severe clinical 
complications for the patients. For example, the myocardial fibrosis, due to heart infarction, is the 
main cause of arrhythmias and heart failure (Chin and Murry, 2012). Biotechnological research 
related to wound healing process is strongly involved in the search of innovative and effective 
treatments, but the obtained results are not satisfying yet. In November 2017, the European Union 
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introduced the Regulation on Advanced Therapies with the goal of better defining rules for 
production and application of Advanced Therapy Medicinal Products (ATMPs), i.e. innovative 
therapies that encompass gene therapy, somatic cell therapy and tissue engineering techniques for 
the treatment of severe chronic conditions (https://ec.europa.eu/health/human-use/advanced-
therapies_en). However, so far, only four ATMPs with orphan designation (Glybera, Strimvelis, 
Zalmoxis, and Holoclar) have been successful in obtaining a market authorization and a 10-year 
market exclusivity. Three had ongoing Pediatric Investigation Plans (PIPs) at the time of 
submission for marketing authorization. One, namely Strimvelis, has obtained a 2-year extension of 
the market exclusivity (Farkas et al., 2017).  
The new frontier of regenerative medicine aims at re-activating and enhancing endogenous 
regeneration pathways, which have been lost during evolution and human ontogenesis. In this 
scenario, platelet by-products are a promising perspective because they are based on a well-
balanced cocktail of more than 300 bioactive factors released by activated platelets following clot 
formation and platelet degranulation. Physiologically, these factors trigger the tissue 
regeneration/repair process and are involved in all subsequent steps of the wound healing 
(Cancedda et al., 2017; Golebiewska and Poole, 2015). Therefore, they could be used as a powerful 
therapeutic tool to trigger and enhance the healing process. Encouraging results have been already 
achieved by the use of different platelet by-products for clinical applications, such as in dental and 
maxillofacial surgery (Kumar et al., 2013) (Cortese et al., 2016), in orthopaedics (Mishra and 
Pavelko, 2006), (Kon et al., 2010) (Randelli et al., 2011), in ophthalmology (Avila, 2014), (Carreras 
et al., 2015). Clinical trials were conducted with Platelet-Rich Plasma (PRP) (Xie et al., 2014) and 
also with autologous Platelet Lysate (PL) (Al-Ajlouni et al., 2014) for the treatment of degenerative 
cartilage diseases demonstrating beneficial effects. 
In the last years, we evaluated the activity of platelet-contained molecules on different tissue cells 
in order to investigate activated pathways leading to tissue healing. In particular, we focused our 
attention on the effects of PL on human locally resident cells such as keratinocytes (El Backly et al., 
2011), osteoblasts (Ruggiu et al., 2013), and chondrocytes (Pereira et al., 2013) or mouse bone 
marrow-derived mesenchymal stem cells (Ulivi et al.,2014). Indeed, not only tissue-specific 
progenitors are activated and take part in the wound healing process, but also circulating cells, 
possibly from bone marrow, could be recruited in the wound site (Lo Sicco et 2015). In the studied 
cell systems, we observed a strong initial and transient pro-inflammatory activity of a Platelet 
Lysate (PL) leading to NF-κB activation and secretion of pro-inflammatory cytokines (El Backly et 
al., 2011; Pereira et al., 2013; Ruggiu et al., 2013), the closure of a scratch wound in culture (El 
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Backly et al., 2011) and a strong activation of quiescent cells, which resumed proliferation keeping 
the ability to differentiate in permissive conditions (Ruggiu et al., 2013). 
In this study, we evaluated the in vitro effects of PL on primary human umbilical vein endothelial 
cells (HUVECs) because the endothelial cells represent the first cell population responding to blood 
extravasation, coagulation, platelet activation and degranulation, and inflammatory milieu. Several 
studies have reported the effects of different platelet derivatives in endothelial cells, such as PRP 
(Kakudo et al., 2014; Martínez et al., 2015; Zahn et al., 2017) and the content of isolated platelets in 
the form of platelet-released supernatant (Kandler et al., 2004) or PL (Barsotti et al., 2013; Ranzato 
et al., 2010). In this study, we focused our attention on the activity of PL obtained by the lysis of 
platelets, which were washed in physiological saline, and consequently not contaminated by 
plasmatic molecules in order to specifically investigate the effects of human platelet content on 
HUVECs. To mimic as much as possible the wound microenvironment, we also included an 
inflammatory stimulus, represented by IL-1α, in our in vitro system. This in vitro system allowed to 
dissect the endothelial cell responses induced during the early stages of the wound healing process. 
We believe that the approach of this study would be useful for providing a rationale for the 
therapeutic use of PL in the treatment of wound healing-related pathologies. In particular, we 
investigated the activity of PL on the modulation of the inflammation-related NF-κB pathway and 
on the secretion of cytokines and factors under both physiological and inflammatory conditions. We 
monitored the proliferation of HUVECs in presence of PL and verified the in vitro angiogenic 
capability of the cells expanded in PL. We focused our attention on the activation of quiescent cells 
by PL investigating the induction of cell proliferation and proliferation-related pathways. Finally, 
we studied the effect of PL on angiogenesis-related pathways covering thus a broad range of cell 
responses induced by the molecules contained in PL and potentially involved in the restoration of 
injured blood vessels. 
2.3. Materials and Methods 
2.3.1. Materials 
Medium 199 with Earle’s Salts, foetal bovine serum (FBS), L-glutamine, penicillin G-streptomycin 
sulphate and trypsin-EDTA were all obtained from Euroclone Life Sciences Division (Milan, Italy). 
10 cm Petri dish, 96-well plate, 24-well plate were derived from Eppendorf S.r.l. (Milan, Italy). 
Recombinant human FGF-acidic (FGF-acidic), recombinant human FGF-basic (FGF-basic), 
animal-free recombinant human EGF and recombinant human interleukin-1α (IL-1α) were 
purchased from Peprotech (London, UK). PHAREPA 25000 U.I./5 mL heparin sodium-salt was 
obtained from PharmaTex Italia (Milan, Italy). Hydrocortisone-water soluble, Bright-LineTM 
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hemacytometer and protease inhibitor cocktail were purchased from Sigma-Aldrich (St. Louis, MO, 
USA). Corning® Matrigel® Growth Factor Reduced Basement Membrane Matrix was acquired 
from Corning (Bedford, MA, USA). TransAMTM NF-κB p65 kit was purchased from Active Motif 
(La Hulpe, Belgium). Prostaglandin E2 ELISA kit was from Cayman Chemical (Ann Arbor, MI, 
USA). NuPAGETM 4-12% Bis-Tris gels were from Invitrogen (Milano, Italy). AmershamTM 
ProtranTM 0.45 µm NC, AmershamTM ECLTM western blotting detection reagents and 
AmershamTM hyperfilmTM ECL were obtained from GE Healthcare (Buckinghamshire, UK). 
Antibodies anti-interleukin-8 (IL-8), anti-interleukin-6 (IL-6), anti-cyclin D1 and anti-actin were 
purchased from Santa Cruz Biotechnology Inc. (Dallas, TX, USA). Antibodies anti-phospho-Akt, 
anti-Akt, anti-phospho-ERK1/2, anti-ERK1/2 and anti-phospho-STAT3 were acquired from Cell 
Signalling Technology (Danvers, MA, USA). Antibody anti-HIF-1α was obtained from BD 
Biosciences (San Jose, CA, USA). 
2.3.2. HUVEC harvest and culture 
Primary Human Umbilical Vein Endothelial Cells (HUVEC) were obtained from “Centro di 
Risorse Biologiche” (CRB) of IRCCS Ospedale Policlinico San Martino (Genova, Italy) following 
the approval of this study by the institutional ethics committee. The CRB obtained the written 
informed consent by every umbilical cord donor. The HUVECs were CD31- and CD106-positive 
(endothelial cell-specific markers) and CD90- and CD45-negative (fibroblast-specific and 
leukocyte-specific markers, respectively) as guaranteed by CRB. The cells were seeded at the 
density of 6.0x103 cells/cm2 into gelatine-coated 10 cm Petri dishes and cultured in Medium 199 
with Earle’s Salts supplemented with 10% (v/v) FBS, 2 mM L-glutamine, 100 U/mL penicillin G, 
100 µg/mL streptomycin sulfate, 100 mg/L heparin, 10 µg/L FGF-acidic, 10 µg/L FGF-basic, 10 
µg/L EGF, 1 mg/L hydrocortisone (complete culture medium). Cells were incubated at 37°C in a 
humidified atmosphere with 5% CO2. Medium was changed 3 times per week and at 80% 
confluence cells were split 1:2 by trypsinization with trypsin-EDTA. For the described experiments, 
HUVECs at passages from 3 to 6 were used. 
2.3.3. Platelet lysate preparation 
Platelet lysate was produced starting from buffy coat samples obtained from the whole blood of 
healthy donors and considered as a waste by Blood Transfusion Centre of IRCCS Ospedale 
Policlinico San Martino (Genova, Italy) within the frame of an agreement between Biorigen Srl and 
IRCCS Ospedale Policlinico San Martino signed on September 2012 and renewed on 2nd February 
2017 (“Deliberazione” n°0084). At the time of blood donation, all donors provided the written 
informed consent for the use of donated blood for clinical and scientific applications. The buffy 
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coats of 5 to 10 donors were pooled for minimizing the variations among donors and centrifuged at 
low speed. Platelet-rich plasma (PRP) was separated and centrifuged at high speed in order to 
sediment the platelets. The pellet was washed 3 times with physiological saline (0.9% w/v NaCl), in 
order to eliminate possible contaminants from plasma. Platelets were suspended in physiological 
saline at a concentration of 10x106 platelets/µL and the suspension was subjected to 3 freeze/thaw 
cycles followed by high-speed centrifugation. The supernatant, containing the cocktail of factors 
released by the platelets re-suspended in physiological saline (Platelet Lysate, PL), was collected 
and stored in aliquots at -20°C until use. Platelet lysate was supplemented to complete culture 
medium at a final concentration of 5% (v/v), approximately corresponding to the highest 
physiological concentration of platelets in the human blood, without adding heparin.  
2.3.4. Proliferation assays 
1) Crystal violet assay: HUVECs were seeded at the density of 2.5x103 cells/well on gelatine-
coated 96-well plate and incubated in complete culture medium for 24h to enable cell 
adhesion. The next day, medium was replaced with complete medium not supplemented 
(control cells) or supplemented with 5% PL (treated cells). The assay was performed in 
quintuplicate for each culture condition after 0, 2, 4 and 6 days of PL stimulation. At each 
time point, the culture media were removed and replaced with 50 µL/well of 0.75% (w/v) 
crystal violet staining solution. After 20 min incubation, the staining solution was discarded 
and wells were extensively washed. When the plate was dry, 100 µL/well of elution solution 
was added and dye absorbance was measured at 595 nm. The average of three independent 
experiments performed on different single-donor primary HUVEC cultures and the fold 
increase of the signal revealed after 6 days of PL treatment over control (mean ± SD) is 
shown.  
2) Cell count: HUVECs were seeded on gelatine-coated 24-well plate and cultured in complete 
culture medium until reaching confluence. The medium was then replaced with complete 
medium supplemented (treated culture) or not supplemented (control culture) with 5% PL. 
At 0, 3, 6, 10 days of PL stimulation, cell density was monitored in triplicate by cell 
counting using a Bright-Line™ Hemacytometer with an improved Neubauer chamber. 
Values are expressed as fold increase with respect to the value obtained at the time of the PL 
addition (first considered time point - day 0). Results are expressed as the average of three 
independent experiments performed on different single-donor primary HUVEC cultures 
(mean ± SD). Cell density ratio between PL-treated and control cells at 10th day of PL 
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treatment is also reported. Ratio was separately calculated in 3 independent experiments and 
expressed as mean ± SD. 
2.3.5. Tube formation assay 
Proliferating HUVECs were cultured in complete culture medium un-supplemented (control) or 
supplemented with 5% PL for a week. The cells were then trypsinized, re-suspended in serum-free 
medium (no supplements) and seeded at the density of 70,000 cells/well on matrigel-coated 24-well 
plate. Images were taken after 6h incubation at 37°C in a humidified atmosphere with 5% CO2. 
2.3.6. Western blot analysis 
To analyse the cytokine production in cell culture media, sub-confluent HUVECs were treated for 
1, 5 or 24h with complete culture medium supplemented with 5% PL, or 100 U/mL IL-1α, or 5% 
PL + 100 U/mL IL-1α, or without any supplement. Cells were then extensively washed with PBS 
for removing residual factors and incubated in serum-free medium (medium 199 with Earle’s Salts 
supplemented only with 2 mM L-glutamine, 100 U/mL penicillin G and 100 µg/mL streptomycin 
sulphate) for 24h. The different media were collected, clarified at 2000 rpm for 10 min at room 
temperature and stored at -20°C. To investigate the PL effect on proliferation-related pathways and 
on cell cycle activation, sub-confluent HUVECs were treated for multiple time intervals with 
complete culture medium supplemented with 5% PL, washed with PBS, and lysed by incubating the 
cell layers on ice for 5 min with an ice-cold buffer containing 50 mM Tris HCl pH 7.5, 150 mM 
NaCl, 1% (w/v) sodium deoxycholate, 1% (v/v) Triton X-100, 0.1% (w/v) sodium dodecyl 
sulphate, 0.2% (w/v) sodium azide and protease inhibitor cocktail. Cell lysates were harvested with 
a cell scraper, clarified at 10000 rpm for 15 min at 4°C and stored at -20°C. For studying HIF-1α 
pathway, cell layers were washed with cold PBS on ice, incubated overnight at -80°C, lysed as 
described above and harvested with cold cell scraper. They were sonicated at 30 amplitude microns 
for 5 seconds, clarified at 10000 rpm for 15 min at 4°C and immediately analysed by western blot. 
The protein content of both conditioned media and cell lysates was quantified by Bradford protein 
assay (Bradford, 1976). 
Electrophoresis was performed in reducing conditions using 25-60 µg of protein loaded on a 
NuPAGETM 4-12% Bis-Tris gel and proteins were transferred to a AmershamTM ProtranTM 0.45 µm 
NC nitrocellulose blotting membrane. The blot was saturated with 5% skimmed cow milk in TTBS 
(20 mM Tris HCl pH 7.5, 500 mM NaCl, 0.1% Tween 20) for 2h at room temperature and washed 
several times with TTBS and probed in a cold room overnight with specific primary antibodies 
raised against IL-8 (1:250 dilution) and IL-6 (1:250 dilution) for the conditioned media or against 
phospho-Akt (1:1000 dilution), Akt (1:1000 dilution), phospho-ERK1/2 (1:1000 dilution), ERK1/2 
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(1:1000 dilution), phospho-STAT3 (1:1000 dilution), Cyclin D1 (1:250 dilution), HIF-1α (1:500 
dilution) and Actin (1:500 dilution) for the cell lysates. After washing, the detection was obtained 
by incubating the blot with secondary horseradish peroxidase-conjugated immunoglobulins G 
(IgGs) for 1h at room temperature. The blot was then washed and incubated with AmershamTM 
ECLTM western blotting detection reagents following manufacturer’s instructions and finally 
exposed to AmershamTM hyperfilmTM ECL to capture the image. For each considered marker, 
western blot was performed on 3 independent experiments corresponding to different single-donor 
primary HUVEC cultures. Densitometric analysis was performed by scanning the film using the 
Epson Perfection V330 Photo scanner (Epson, Italy) and quantifying the band densities using 
ImageJ software (https://imagej.nih.gov/ij/download.html). Presented results are the average of 3 
independent experiments ± SD values.  
2.3.7. NF-κB activity assay 
To evaluate the nuclear factor-κB (NF-κB) activity, TransAMTM NF-κB p65 kit was used. This 
ELISA-based kit is based on the binding of NF-κB active form to an oligonucleotide, containing 
NF-κB consensus decameric sequence 5’-GGGACTTTCC-3’, immobilized on a 96-well plate. Sub-
confluent HUVECs were treated for 1h or 16h with complete culture medium supplemented with 
5% PL, 100 U/mL IL-1α, or 5% PL + 100 U/mL IL-1α, or without any supplement (control). Media 
were removed and cells washed with PBS. Whole-cell extracts were prepared following 
manufacturer’s instructions. The NF-κB active form contained in the whole-cell extracts 
specifically binds to the consensus sequence and the primary antibody recognizes an epitope on 
subunit p65, which is accessible only when NF-κB is activated and bound to its target site. An 
HRP-conjugated secondary antibody provides a colorimetric signal quantified by 
spectrophotometry. Specificity of the assay was checked by adding soluble wild-type and mutated 
consensus oligonucleotides acting as competitors for NF-κB binding. For the reported 
representative experiment, results are expressed as the absorbance values measured in the presence 
of the mutated oligonucleotide minus those measured in the presence of the wild-type 
oligonucleotide. This assay was performed in triplicate on 3 independent experiments 
corresponding to different single-donor primary HUVEC cultures. For each stimulation time, the 
over the control fold increase of NF-κB activity induced by IL-1α stimulation and the percentage 
value of NF-κB activity induced by PL+IL-1α treatment with respect to IL-1α net increase are 
reported (means ± SD). 
2.3.8. PGE2 quantification 
To quantify the PGE2 production, Prostaglandin E2 ELISA kit was used. This assay is based on the 
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competition between PGE2 present in the sample and a PGE2 tracer for a limited amount of anti-
PGE2 monoclonal antibody. Sub-confluent HUVECs were treated for 24h with complete culture 
medium supplemented with 5% PL, 100 U/mL IL-1α, or 5% PL + 100 U/mL IL-1α, or without any 
supplement (control). Cells were then extensively washed with PBS for removing residual factors 
and then incubated in serum-free medium for 24h. The different conditioned media were collected 
and assayed following manufacturer’s instructions. Results are expressed as fold change referring to 
control. This assay was performed in duplicate on 3 independent experiments corresponding to 
different single-donor primary HUVEC cultures. 
2.3.9. Statistical analysis  
All data are presented as means and standard deviations based on independent experiments 
performed on three different primary HUVEC cultures, each of them derived from a single donor. 
The statistical analysis was performed using the unpaired t-Test for NF-κB activity and proliferation 
assays or using the ordinary one-way ANOVA for IL-8, IL-6, Cyclin D1, HIF-1α and phospho-
STAT-3 densitometric analysis and PGE2 quantification. If ANOVA detected statistically 
significant differences within the data set, Tukey’s or Dunnett’s multiple comparison tests were 
used to calculate the significant differences for IL-8 and IL-6 densitometric analysis and PGE2 
quantification or for Cyclin D1, HIF-1α and phospho-STAT-3 densitometric analysis, respectively. 
All tests were run setting a confidence interval of 95% (p<0,05). 
2.4. Results 
2.4.1. PL down-regulates NF-κB pathway in an inflammatory milieu  
Having in mind that bioactive molecules released by platelets trigger the wound healing process and 
that this process takes place in an inflammatory microenvironment, we focused our attention on the 
response of endothelial cells to PL in both normal conditions and in the presence of inflammatory 
cytokines. In particular, we evaluated the activation of NF-κB pathway, a key player in the 
inflammatory phase response (Lawrence, 2009), in sub-confluent HUVECs treated for 1h or 16h 
with complete culture medium supplemented with 5% PL, or 100 U/mL IL-1α, or 5% PL+100 
U/mL IL-1α or un-supplemented (control, CTR). Figure 1, Panel A, reports the NF-κB activity in a 
representative experiment where cells were exposed to different culture conditions. Panels B shows 
the over the control fold increase of NF-κB activity induced by IL-1α stimulation for 1 hour and the 
percentage reduction in the IL-1α-induced NF-κB activity when the culture was supplemented also 
with PL. Panel C shows the fold increase and the percentage reduction after 16h stimulation of the 
cells. Values are reported as average values ± SD values of 3 independent experiments. The NF-κB 
activity increase was statistically significant with respect to control after both 1h and 16h cell 
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stimulation with IL-1α (p=0.0413 and p=0.0062, respectively, Figure 1B,C), and statistically 
significantly decreased after both 1h and 16h stimulation in cells treated with PL+IL-1α with 
respect to the IL-1α treated cells (p=0.0018 and p=0.0292, respectively, Figure 1B,C). These results 
indicate an anti-inflammatory activity of PL on HUVECs both at early and late times.  
Considering the negative regulation of NF-κB pathway by PL in an inflammatory milieu, we 
evaluated the production of two pro-inflammatory cytokines, IL-8 and IL-6, following 1h and 24h 
stimulations with PL under both physiological and inflammatory conditions. By western blot 
analysis of conditioned media, we did not observe a significant variation of pro-inflammatory 
cytokine secretion induced by IL-1α in PL+IL-1α treated cells. The reported densitometric analyses 
refer to the average of 3 or 4 independent experiments performed on different primary HUVEC 
cultures for 1h or 24h stimulations, respectively (Figure 2A,B).  
2.4.2. PL increases PGE2 secretion by HUVEC in an inflammatory milieu 
In a previous publication from our laboratory, we demonstrated a pro-resolving activity of Platelet 
Rich Plasma on cells of the immune system to create an anti-inflammatory microenvironment 
related to PGE2 production (Papait et al, 2017). A quantitation of PGE2 released by HUVECs in the 
presence of PL was performed in order to detect a possible protective activity in an inflammatory 
environment. Results reported in Figure 3 show a significant increase of PGE2 secretion in PL+IL-
1α treated cells with respect to the control (p=0.0191) indicating that PL-activated HUVECs could 
contribute to resolution of tissue inflammation also by a paracrine mechanism. 
2.4.3. PL enhances proliferation of HUVECs retaining their differentiation capability 
The PL effect on HUVEC viability and proliferation was evaluated at different times from the PL 
addition by crystal violet staining assay performed on 3 independent primary cultures. Cells treated 
with the complete culture medium supplemented with 5% PL had a higher proliferation rate with 
respect to control cells in complete medium with no supplement, with a significant (1.83±0.31)-fold 
increase of the signal induced by PL at day 6th with respect to the control signal (p=0.0092; Figure 
4A,B). We did not observe any significant change in the cell morphology between PL-treated cells 
and control cells. We did not observe qualitative differences between treated and control cells about 
their angiogenic capability. Cells grown in PL for 1 week kept the ability to form capillary-like 
structures when seeded on matrigel (Figure 4 C, D). 
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2.4.4. PL promotes the proliferation of quiescent HUVECs, activates Akt and ERK 
pathways, and induces Cyclin D1 expression 
Considering the enhancement of cell proliferation induced by PL on HUVECs and our previous 
study on human osteoblasts demonstrating an activation of quiescent cells by PL (Ruggiu et al., 
2013), we cultured HUVECs in complete culture medium until reaching the confluence state, and 
we treated the cells with complete medium supplemented with 5% PL or not supplemented 
(control) for 10 days. We monitored cell growth by cell counting at different time intervals. PL 
induced proliferation of confluent cells that reached a higher (1.72 ± 0.33)-fold cell density then 
control cells (p=0.0201) at day 10th (Figure 5A,B). For each experimental condition, we report the 
values expressed as fold increase with respect to the first considered time point (day 0). The average 
values ± SD of 3 independent experiments are shown. We also investigated the modulation of 
proliferation-related Akt and ERK pathways (Mebratu and Tesfaigzi, 2009; Yu and Cui, 2016)  and 
the expression of the cell cycle associated Cyclin D1 following PL treatment. Sub-confluent cells 
maintained in complete medium were treated with 5% PL. Cell lysates were collected at different 
times from the PL addition and analysed by western blot. Activation of both Akt and ERK 
pathways was observed already 10 min after PL treatment followed by a progressive decrease, more 
rapid for Akt than for ERK (Figure 5C). Three independent experiments performed on different 
primary HUVEC cultures yielded the same results. The analysis of the Cyclin D1 expression 
showed that the expression level of Cyclin D1 was significantly enhanced already after 1h of PL 
treatment reaching its maximum level at 4h (p=0.0274 for 0h versus 1h and p=0.0049 for 0h versus 
4h, Figure 5D) and decreasing at later times. The densitometric analysis of western blots for Cyclin 
D1 expression as the average of 3 independent experiments performed on different primary 
HUVEC cultures (mean ± SD) is reported in Figure 5D. 
2.4.5. PL activates the angiogenesis-related HIF-1α and STAT3  
In tissue wound, the vascular injury leads to a stop of the blood flow and a consequent ischemia and 
hypoxia. The re-establishment of a blood vasculature through the process of angiogenesis is 
necessary for delivering oxygen and nutrients to the healing site. Hypoxia induces activation of 
HIF-1α, a transcription factor that accumulates in the wounded tissue cells and also in endothelial 
cells (Ahluwalia and Tarnawski, 2012; Dal Monte et al., 2011), and induces VEGF gene expression. 
In addition to oxygen depletion, HIF-1α activation can be induced also in normoxic conditions by 
several factors such as cytokines, growth factors and microbe-derived components. Indeed, HIFs 
are transcription factors able to induce the expression of genes necessary for cell survival and 
metabolism under a variety of hostile conditions (for a review see Shi et al., 2017). 
We investigated a possible involvement of PL in wound re-vascularization. We here report that PL 
	 25 
significantly induced HIF-1α in HUVECs after 24h stimulation (0h versus 24h p=0.0123, Figure 
6A). In agreement with a possible implication of PL in restoring blood vasculature in wounded 
tissues, we also observed a very rapid and transient activation of STAT3 (0h versus 10’ p=0.0405, 
Figure 6B), a critical transcription pathway in angiogenesis (Chen and Han, 2008). 
2.5. Discussion 
Injured blood vessel repair and blood circulation re-establishment are crucial events for tissue 
repair. Our work focuses on the behaviour of endothelial cells in a wound-like microenvironment 
physiologically characterized by the presence of inflammatory cytokines and by the transition from 
plasma to serum, i.e. from plasma to a mixture of plasma proteins and growth factors and bioactive 
molecules released by activated platelets. The new microenvironment plays a major role in 
restoring tissue function, but, at the end of the healing process, when the blood circulation is 
restored in the newly formed tissue, cells are again exposed to plasma. Indeed, the plasma to serum 
transition is necessary for proper healing, but serum must be replaced by plasma for reactivation of 
tissue function (LeBrasseur, 2006).  
In this paper, we showed that Platelet Lysate (PL), used at a concentration approximately 
corresponding to the highest physiological concentration of platelets in the human blood, could 
modify the behaviour of endothelial cells, thus playing a significant role in the different phases of 
tissue healing: 
i) PL induced resolution of inflammation by inhibiting IL-1α-activated NF-κB pathway. 
Physiologically, after an injury, platelets leak from damaged blood vessels and the 
inflammatory phase is initiated by the platelet degranulation leading to the release of growth 
factors acting as key players in the tissue healing process. The inflammatory phase is 
characterized by the clearance of microbial contamination and the removal of devitalized 
tissue by migrating macrophages. We previously investigated the effect of PL in an 
inflammatory milieu in several cell systems and we demonstrated an early and transient 
activation of the pro-inflammatory NF-κB pathway induced by IL-1α in human 
keratinocytes, osteoblasts, chondrocytes, and murine BMSC (El Backly et al., 2011; Pereira 
et al., 2013; Ruggiu et al., 2013; Ulivi et al., 2014). This early activation was paralleled by 
an early and increased secretion of pro-inflammatory cytokines IL-6 and IL-8 and, in 
keratinocytes, also by an increased production of the antimicrobial lipocalin NGAL. This 
effect was transient because, after the early inflammatory burst, PL inhibited IL-1α-induced 
NF-κB activation (Pereira et al., 2013). This finding was in agreement with other reports 
that showed a pro-resolving activity of PL and/or PRP (Xie et al., 2014). We believe that 
platelet released factors exerts an immediate pro-inflammatory effect causing an immediate 
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antimicrobial response by the tissue that releases antimicrobial proteins such as NGAL (El 
Backly et al., 2011), and the migration of neutrophils and macrophages (Tasso et al., 2013a) 
that engulf contaminant microorganisms and remove the devitalized tissue. At later time PL 
exerts an opposite effect by inhibiting NF-κB activation and promoting resolution of the 
inflammatory phase.  
Given that endothelial cells are the first cells in contact with PL after vessel injury, we 
treated HUVECs with PL for different times in presence or not of IL-1α. The PL inhibited 
IL-1α-induced NF-κB activation already after 1-hour treatment as well as after 16-hours 
treatment showing an anti-inflammatory activity at both the early and the late considered 
times. This finding is in agreement with the anti-inflammatory activity of PRP described in 
literature (Mazzocca et al., 2013) and provides a possible rationale to this effect. We also 
observed that, at variance with the other so far investigated cell systems, PL did not 
significantly enhance the production of IL-6 and IL-8 induced by IL-1α, nor induce a 
significant repression, although the trend was a decrease in the secretion of these two 
cytokines. The response of the different assayed primary cultures was quite variable as 
demonstrated by the standard deviation. Taken together, the data suggest that endothelial 
cells are protected by PL in the inflammatory milieu of the wound. 
ii) PL increased PGE2 secretion in the presence of inflammatory cytokines.  
A significant increase of PGE2 secretion in inflammatory conditions was detected indicating 
that PL activated HUVECs possibly to contribute to resolution of tissue inflammation. 
Indeed, an anti-inflammatory activity of PGE2 was demonstrated toward macrophages, 
inducing the functional switch from M1 inflammatory phenotype to M2 pro-resolving 
phenotype (Maggini et al., 2010). In a previous publication from our laboratory, it was also 
demonstrated a pro-resolving activity of Platelet Rich Plasma on cells of the immune system 
to create an anti-inflammatory microenvironment related to PGE2 production (Papait et al., 
2017). The presented results provide an additional indication that PL exerts an early anti-
inflammatory activity on HUVECs. 
iii) PL enhanced proliferation of HUVECs without affecting their differentiation capability.  
Our goal was to dissect the system and to specifically investigate the effect of human 
platelet-contained molecules on endothelial cells maintained in standard culture conditions, 
i.e. in the presence of foetal bovine serum. Platelet lysate enhanced the proliferation of 
HUVECs, without affecting their capability of forming tube-like structures on matrigel. Our 
findings are in agreement with reported data referring that platelet-released molecules 
support proliferation of cells from different tissues, including endothelial cells, showing a 
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significantly lower apoptosis and increased proliferation rates (Denecke et al., 2015). The 
maintained capacity of endothelial cells expanded in PL to form tube-like structures on 
matrigel is in agreement with Tasev et al., 2015, although, in that study, the platelet lysate 
was made in human plasma and was used as serum substitute. 
iv) PL induced proliferation of quiescent HUVECs.  
We previously reported that quiescent cultured osteoblasts exposed to PL resumed 
proliferation retaining their differentiation capability (Ruggiu et al., 2013). In the present 
study, we observed that resting confluent HUVECs were activated by PL that induced cell 
proliferation up to a cell concentration approximately double than the one of not PL 
stimulated, control cells. This observation also suggested a possible change in the HUVEC 
size as reported for human MSCs (Chevallier et al., 2010) and for human osteoblasts 
(Ruggiu et al., 2013). In agreement with these findings, proliferation-related pathways Akt 
and ERK were activated as well as the expression of the cell cycle activator Cyclin D1 
enhanced. We consider this an important finding because clot formation and platelet 
degranulation are the first tissue’s response to an injury and, in particular, the multitude of 
platelet-released factors able to attract circulating cells and to restore the proliferation of 
resting resident cells physiologically leads to the tissue repair through the complex series of 
events typical of the wound healing process. Eventually, only after the effective repair of the 
injured tissue, normal blood perfusion resumes.  
It was demonstrated that HUVECs and HAECs (Human Aortic Endothelial Cells) derived 
from vessel walls, considered normally differentiated endothelial cells, contain a complete 
hierarchy of endothelial progenitor cells (EPCs) and that a diversity of EPCs exists in 
human vessel playing an important role in maintaining vessel integrity (Ingram, 2005). We 
demonstrated that resting cultured confluent HUVECs are activated and resume 
proliferation following a PL treatment suggesting that an activation of the resident cell 
population, possibly progenitors and differentiated cells, could occur also in vivo after an 
injury. 
Several studies reported that EPCs can be isolated also from adult peripheral and umbilical 
cord blood. These progenitors are thought to originate from bone marrow, to circulate in the 
peripheral blood and to be involved in neovascularization and wound healing (Tasso et al., 
2010, Balaji et al., 2013; Shi et al., 2017). However, mechanisms for vessel repair in wound 
are not currently well defined. Cells from bone marrow are recruited to the site of injury by 
migration trough the blood circulation, whereas cell activation and recruitment from vessel 
walls occurs via direct activation of local cells. We believe that, in the process of injury 
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repair, cells recruited from bone marrow and resident cells contribute to new vessel 
formation in an extent that may vary depending on the type of injury and possibly on the 
tissue type involved. 
v) PL induced HIF-1α protein stabilization and STAT3 activation: implication in angiogenesis.  
Tissue injury leads to the destruction of blood vessels and the disruption of local blood 
perfusion resulting in a hypoxic state that requires the adaptive response of local cells, 
including vascular precursor cells, responding to the produced stimuli. Hypoxia-inducible 
transcription factors (HIFs) are a complex of factors that regulate the cell response to 
hypoxia. The HIF-1α subunit, present in the cell, is physiologically degraded by the 
ubiquitine system, but is stabilized by hypoxia and migrate to the nucleus as a complex with 
HIF-1β and co-activators, which together activate transcription of over 100 responding  
genes (Liu et al., 2012). These genes are important for cell survival and metabolism. Indeed, 
HIFs can be induced also in normoxic conditions by various stimuli, such as cytokines, 
growth factors, reactive oxygen or nitrogen species and microbial components, occurring in 
injury and hostile conditions (Richard et al., 2000). The activation of HIF pathway by PL 
was recently reported in cartilage cells by a paper from our laboratory (Nguyen et al., 2017). 
Angiogenesis, i.e. the formation of new blood vessels from the pre-existing vasculature, is a 
complex process regulated by signal transduction pathways leading to the expression and 
activation of angiogenic molecules. It was demonstrated that in HUVECs the hypoxia 
induced the HIF-1α stabilization driving angiogenesis (Dal Monte et al., 2011; Yu et al., 
2015) and that bFGF in normoxic condition induced HIF-1α stabilization and tubular 
structure formation (Calvani et al., 2006). It was also shown that STAT3 signalling is 
important and necessary for endothelial cell proliferation, migration, and microvascular tube 
formation (Chen and Han, 2008) and also for in vivo angiogenesis induction (Valdembri et 
al., 2002).  
We reported that platelet-released factors induced the stabilization of HIF-1α and the 
phosphorylation of STAT3 in agreement with an involvement of PL in the activation of 
angiogenesis. 
In conclusion, in this paper, we demonstrated a beneficial activity of PL treatment on HUVECs by 
the inhibition of inflammation, the enhancement of proliferation of cells, which retained the 
differentiation capability, the resumption of proliferation of quiescent cells and the activation of 
angiogenesis-related pathways, thus providing a rationale for the clinical use of PL in wound 
healing. 
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2.10. Figures & Legends 
 
Figure 1: Modulation of NF-κB pathway in HUVEC treated with PL under physiological and 
inflammatory conditions. Sub-confluent HUVEC were treated for 1h or 16h with complete medium 
supplemented with 5% PL, or 100 U/mL IL-1α, or 5% PL+100 U/mL IL-1α or un-supplemented 
(control, CTR). Whole-cell extracts were analysed by ELISA-based TransAMTM NF-κB p65 kit. 
(A) Absorbance values of NF-κB activity after 1h and 16h stimulation related to a representative 
experiment. (B), (C) Cell NF-κB activity after 1h and 16h stimulation, respectively, expressed as 
fold increase over control following IL-1α treatment and percentage value following PL+IL-1α 
treatment with respect to IL-1α induced net increase (100%, after the subtraction of control value). 
For each condition, the average of 3 different experiments (mean ± SD) assayed in triplicate on 
different single-donor primary cultures are reported. For 1h stimulation, * and ** symbols refer to 
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p=0.0413 and p=0.0018, respectively. For 16h stimulation, * and ** symbols refer to p=0.0292 and 
p=0.0062, respectively.  
 
 
Figure 2: Pro-inflammatory cytokine secretion by HUVEC following PL stimulation under both 
physiological and inflammatory conditions. Sub-confluent HUVEC were treated for 1h or 24h with 
complete medium supplemented with 5% PL, or 100 U/mL IL-1α, or 5% PL+100 U/mL IL-1α, or 
without any supplement (control, CTR). At the end of the different stimulations, the supplemented 
media were removed and replaced with serum-free medium. After 24h incubation, the conditioned 
media were collected. Western blot analysis of conditioned media for the secretion of IL-8 (A) and 
IL-6 (B). The densitometric analysis of western blots was performed on 3 or 4 independent single-
donor primary cultures (means ± SD) for 1h or 24h treatments, respectively. The * symbol 
represents significant differences with p≤0.0494. Under densitometric analysis histograms, 
representative western blots are shown. 
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Figure 3. PGE2 secretion by HUVEC following PL stimulation under both normal and 
inflammatory conditions. Sub-confluent HUVEC were treated for 24h with complete medium 
supplemented with 5% PL, or 100 U/mL IL-1α, or 5% PL+100 U/mL IL-1α, or without any 
supplement (control, CTR). Media were removed and replaced with serum-free medium for 24h 
incubation. The conditioned media were collected and analysed by Prostaglandin E2 ELISA kit. For 
each condition, PGE2 production is expressed as fold change with respect to CTR. The average 
values and relative standard deviation values of 4 determinations performed in duplicate on 3 
different single-donor primary cultures are presented. The * symbol represents a significant 
difference with p=0.0191.  
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Figure 4: PL effect on proliferation, morphology and angiogenic capability of HUVEC. (A) 
Proliferation of HUVECs treated with the complete medium supplemented with 5% PL or un-
supplemented (control, CTR) evaluated at different time intervals by crystal violet staining assay. 
The average values ± SD of 3 independent experiments performed in quintuplicate on different 
single-donor primary cultures are reported. (B) Fold increase of the signal revealed after 6 days of 
PL treatment over control (CTR) expressed as mean ± SD of 3 independent experiments. The ** 
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symbol refers to p=0.0092. (C) Morphology of HUVECs cultured in complete medium un-
supplemented (control cells, CTR) or supplemented with 5% PL for 6 days. Scale bar = 150 µm. 
(D) Tube-like structure formation assay performed on matrigel using HUVECs grown in complete 
medium un-supplemented (control cells, CTR) or supplemented with 5% PL for 7 days. The assay 
was performed in the absence of PL. Two pictures related to different positions in the well per 
condition are reported. Scale bar = 250 µm. 
 
 
Figure 5: Proliferation of quiescent HUVEC in the presence of PL, modulation of Akt and ERK 
pathways and activation of cell cycle by PL. (A) Proliferation of confluent HUVEC maintained in 
complete medium (CTR) or treated with complete medium supplemented with 5% PL monitored by 
cell counting. The values were expressed as fold increase related to the value obtained at the first 
considered time point (day 0). The average values ± SD of 3 determinations performed in triplicate 
on 3 different single-donor primary HUVEC cultures are shown. (B) Cell density ratio between PL-
treated and control cells (CTR) at day 10th of PL treatment. Ratio was separately calculated in 3 
independent experiments and expressed as mean ± SD. The * symbol refers to p=0.0201. (C) 
Western blot analysis of sub-confluent HUVEC treated with complete medium supplemented with 
5% PL for multiple times. Cell lysates were analysed by western blot with antibodies raised against 
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phospho-Akt, Akt, phospho-ERK1/2, ERK1/2 and Actin. The Akt, ERK1/2 and Actin were used as 
internal controls. Three independent experiments performed on different primary HUVEC cultures 
yielded the same results. (D) The PL effect on cell cycle of sub-confluent cells treated with 5% PL 
in complete medium for different times. A western blot analysis of the cell lysates was performed to 
evaluate the Cyclin D1 expression. In the upper panel, the densitometric analysis of Cyclin D1-
probed western blots performed on 3 independent single-donor primary cultures is reported (means 
± SD). The * and ** symbols represent significant differences with p=0.0274 and p=0.0049, 
respectively. In the lower panel, a representative western blot for Cyclin D1 is shown. Actin was 
blotted as an internal control.  
 
 
Figure 6: Stabilization of HIF-1α and activation of STAT3 in HUVECs by PL. (A) Western blot 
analysis of HUVECs incubated at sub-confluence in serum-free medium for 2h and treated for 
multiple time intervals with serum-free medium supplemented with PL. Corresponding cell lysates 
were analysed by western blot with antibody raised against HIF-1α. Actin was probed as internal 
control. In the upper panel, the densitometric analysis of HIF-1α-probed blots shows means ± SD of 
3 independent single-donor primary cultures. The significant difference 0h versus 24h corresponds 
to p=0.0123 (*). In the lower panel, a representative western blot for HIF-1α is shown. (B) Western 
blot analysis of sub-confluent HUVECs treated with complete medium supplemented with 5% PL 
for multiple time intervals. Corresponding cell lysates were analysed by western blot with antibody 
raised against phospho-STAT3. Actin was probed as internal control. In the upper panel, the 
densitometric analysis of pospho-STAT3-probed blots performed on 3 independent single-donor 
primary cultures is reported (means ± SD). The significant difference 0h versus 10’ corresponds to 
p = 0.0405 (*). In the lower panel, a representative western blot for pospho-STAT3 is shown. 
	 40 
3. PLATELET LYSATE EFFECT ON HUMAN SUBCUTANEOUS ADIPOSE TISSUE: 
INDUCTION OF PROGENITOR CELL PROLIFERATION AND SECRETION OF 
INFLAMMATION-RELATED CYTOKINES AND FACTORS – PAPER IN 
PREPARATION  			
Alessio Romaldini1 et al. 
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3.1. Introduction 
When tissue or organ is affected by injury or disease, the human body responds immediately by 
activating the wound-healing cascade. However, large and deep lesions and organ failure determine 
fibrosis and scar formation, which are causes of reduction or loss of functionality. Regenerative 
medicine was born and grew up with the aim of delaying scarring process and promoting as much 
as possible regeneration of tissue or organ structure and homeostasis. “Classical” regenerative 
strategies are based on separated or combined use of biomaterials and stem/progenitor cells but they 
are still not broadly used in the clinical practice. We strongly think the new frontier of regenerative 
medicine should head towards approaches able to reactivate and enhance dormant endogenous 
regenerative mechanisms (Cancedda, Bollini, Descalzi, Mastrogiacomo, & Tasso, 2017). The 
fundamental condition for designing clinically suitable tools is to know in detail tissue’s natural 
response to injury or disease in order to be able to identify those pathways, among the all, to be 
activated and those ones to be limited.  
In the humans, postnatal epidermis is one of the tissues with the highest regenerative potential. 
However, when an injury affects the underlying dermal layer, the wound healing leads to scar 
formation. In some circumstances, an aberrant repair process of skin lesions can determine serious 
consequences, such as pathological scarring (hypertrophic scar or keloid) or chronic wounds 
(Eming, Martin, & Tomic-Canic, 2014). In particular, chronic wounds are non-healing ulcerative 
defects of the skin, which arise in association with disease states (e.g. vascular diseases or diabetes 
mellitus) or in presence of systemic factors (e.g. advanced age), and represent a very important 
worldwide medical and economic issue. In the United States alone, chronic wounds affect around 
6.5 million patients with estimated US$ 25 billions for the healthcare system. In Western countries, 
it has been estimated that 1-2% of the population will experience a chronic wound during their 
lifetime (Sen et al., 2009). For the treatment of chronic wounds, the new therapeutic approaches are 
based on in situ administration of bioactive molecules, incorporated or not in wound dressings, for 
enhancing the physiological healing process. In this scenario, platelet by-products could be 
promising clinical tools. In particular, it was reported that platelet-rich plasma (PRP), which is an 
autologous blood platelet-based derivative, can improve the healing of chronic wounds even if there 
are in literature some contradictory outcomes considering the aetiologies of wounds (Martinez-
Zapata et al., 2012; Suryanarayan, Budamakuntala, Suresh, & Sarvajnamurthy, 2013; Suthar, 
Gupta, Bukhari, & Ponemone, 2017). Focusing our attention on the molecular mechanism of 
platelet-derived factors in skin wound healing, we previously studied the effects of human platelet 
lysate on human keratinocytes showing that platelet lysate stimulated resting cells to produce 
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increased levels of IL-8 and of the antimicrobial peptide NGAL in inflammatory condition, via p38 
MAPK and NF-κB activation, and promoted an accelerated wound closure in an in vitro scratch 
assay (El Backly et al., 2011).  
Starting from these findings, we addressed our interest in the role of human subcutaneous adipose 
tissue in supporting the repair process of skin wounds because such tissue is located beneath the 
skin and physiologically contribute to re-establish the homeostasis of the damaged skin. In this 
study, we investigated the in vitro response of subcutaneous adipose tissue to human platelet 
content in order to shed light on those endogenous pathways potentially activated following the 
injury. For this purpose, we defined a clinically relevant model using the early injury-associated 
stimuli, which are Human Serum (HS), Platelet Lysate (PL) and Interleukin-1α (IL-1α), in order to 
reproduce in vitro as much as possible in situ microenvironment establishing during deep skin 
injury. In particular, HS played the role of serum, which is the physiological fluid at the wound site, 
while PL corresponded to that well-balanced cocktail of more than 300 bioactive molecules 
physiologically released by activated platelets during haemostasis and involved in all steps of the 
wound healing process (Cancedda et al., 2017; Golebiewska & Poole, 2015). Because of the 
manufacturing procedures, HS was not contaminated by platelet-derived factors and PL did not 
contain plasmatic molecules allowing to study their separated and combined effects on adipose 
tissue. The IL-1α is physiologically involved in the induction and the maintenance of local 
inflammatory responses (Di Paolo & Shayakhmetov, 2016) and was used to create an inflammatory 
microenvironment. In this manner, we wanted to dissect the system and specifically elucidate the 
effects of platelet content on subcutaneous adipose tissue in order to give a rationale to the 
therapeutic use of PL for the treatment of chronic wounds. The considered stimuli were tested in 
two types of adipose tissue culture: primary culture of human adipose-derived stromal cells 
(hASCs), used as in vitro paradigm of resident progenitor cells, and ex vivo culture of in toto human 
adipose tissue (hAT). We, first, examined the proliferative and differentiation capabilities of hASCs 
expanded in HS in comparison with cells expanded in foetal bovine serum (FBS). We, then, studied 
PL effect on the proliferation of HS-expanded cells, in absence or presence of IL-1α, focusing our 
attention on the activated growth-related pathways. We also investigated the hASC inflammatory 
response to PL, in both physiological and inflammatory microenvironment, in terms of released 
bioactive factors and activated pathways. We, finally, studied the proliferative response of hAT 
cultured ex vivo with HS in presence or absence of PL under normal or inflammatory conditions in 
order to reduce the gap between in vitro results and in vivo events associated with adipose tissue 
repair process. 
	 43 
3.2. Materials and Methods 
3.2.1. Materials 
Type I collagenase was purchased from Worthington (Lakewood, NJ, USA). The MEM Alpha 
Medium (1X) GlutaMAX™ without nucleosides (αMEM) was from Gibco (Thermo Fisher 
Scientific, Waltham, MA, USA). Foetal bovine serum (FBS), penicillin G-streptomycin sulphate 
solution and normal goat serum were from Euroclone Life Sciences Division (Milan, Italy). 
Dimethyl sulphoxide (DMSO) was obtained from Panreac (Barcelona, Spain). Human interleukin-
1alpha (IL-1α) was from PeproTech (London, UK). Bright-Line™ Hemacytometer with an 
improved Neubauer chamber, crystal violet powder, thiazolyl blue tetrazolium bromide (MTT), 
insulin from bovine pancreas, dexamethasone, L(+)-ascorbic acid sodium salt, β-glycerophosphate 
disodium salt hydrate, Oil Red O (ORO), Alizarin Red S (ARS), paraformaldehyde, protease 
inhibitor cocktail and poly-L-lysine solution were purchased from Sigma-Aldrich (St. Louis, MO, 
USA). Formaldehyde 37% weight solution was from Chem-Lab (Zedelgem, Belgium). Methylene 
blue hydrate powder was purchased from Honeywell Riedel-de Haën® (Seelze, Germany). The 
RNeasy® Plus Micro Kit and Omniscript® RT Kit were from Qiagen (Milan, Italy). Power 
SYBR® Green PCR Master Mix and 7500 Fast Real-Time PCR System were from Applied 
Biosystems® Life Technologies (Thermo Fisher Scientific, Waltham, MA, USA). The NuPAGETM 
4-12% Bis-Tris gels and streptavidin-peroxidase of HistoMouseTM-SP kit were from Invitrogen 
(Thermo Fisher Scientific, Waltham, MA, USA). AmershamTM ProtranTM 0.45 µm NC, secondary 
anti-rabbit and anti-mouse horseradish peroxidase-linked immunoglobulins G (IgGs), AmershamTM 
ECLTM western blotting detection reagents and AmershamTM HyperfilmTM ECL were obtained from 
GE Healthcare (Buckinghamshire, UK). Primary antibodies raised against interleukin-8 (IL-8), 
interleukin-6 (IL-6), Cyclin D1 and Actin were purchased from Santa Cruz Biotechnology Inc. 
(Dallas, TX, USA). Primary antibodies raised against phospho-Akt, Akt, phospho-ERK1/2, ERK1/2 
and phospho-STAT3 were acquired from Cell Signalling Technology (Danvers, MA, USA). 
Primary antibodies raised against cyclooxygenase-2 (COX-2) and microsomal prostaglandin E 
synthase-1 (mPGES-1) and Prostaglandin E2 ELISA kit were from Cayman Chemical (Ann Arbor, 
MI, USA). Secondary anti-goat peroxidase-conjugated immunoglobulins G (IgGs) were from 
Jackson ImmunoResearch (Bar Harbor, MA, USA). Primary antibody raised against PCNA was 
from Abnova (Taipei City, Taiwan). Secondary biotinylated immunoglobulins G (IgGs) and 3,3’-
diaminobenzidine (DAB) were from Dako (Carpinteria, CA, USA). 
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3.2.2. HS and PL production 
The Human Serum (HS) and the Platelet Lysate (PL) were obtained from healthy blood wastes of 
Blood Transfusion Centre of IRCCS Ospedale Policlinico San Martino (Genova, Italy) within the 
frame of an agreement between Biorigen Srl and IRCCS Ospedale Policlinico San Martino signed 
on September 2012 and renewed on 2nd February 2017 (“Deliberazione” n°0084). At the time of 
blood donation, all donors provided the written informed consent for the use of donated blood for 
clinical and scientific applications. In particular, both reagents were produced as pool of several 
blood donors (at least 3 donors for HS or 25 donors for PL) in order to minimize the variations 
among donors. According to the standard procedure, the whole blood units were centrifuged at high 
speed obtaining different phases: the plasma at the top, the buffy coat layer (enriched in platelets 
and leukocytes) at the interface and the red blood cell fraction at the bottom. The HS was produced 
starting from fresh frozen plasma (FFP) units, which are de facto devoid of platelets. Each FFP unit 
was slowly thawed at 4°C in order to produce a cryoprecipitate containing fibrinogen and other 
coagulation factors. The complete clotting was obtained by adding calcium chloride (2 mg/mL) to 
the liquid phase and incubating at 37°C for 6 hours. After a high-speed centrifugation, the 
supernatant (i.e. HS) was collected and pooled with the others. The pool was divided into aliquots 
then lyophilized and stored at -20°C until use. In this work, HS was added in the complete culture 
medium at the same concentration of FBS (10%, v/v) used in the control medium according to the 
gold standard for expanding hASCs. The PL was produced starting from buffy coat samples, which 
were pooled and centrifuged at low speed. After this centrifugation, the lower phase, enriched in 
platelets and indicated as platelet-rich plasma (PRP), was separated and centrifuged at high speed in 
order to sediment the platelets. The platelet pellet was washed 3 times with physiological saline 
(0.9% w/v NaCl), in order to eliminate possible plasma-derived contaminants. The platelets were 
re-suspended and concentrated to 10x106 platelets/µL. The platelet concentrate was subjected to 3 
consecutive freeze/thaw cycles for breaking the cell plasma membranes. After a high-speed 
centrifugation, the supernatant containing the cocktail of platelet-released factors (PL) was 
collected and combined with the other supernatants. The pool was divided in aliquots, lyophilized 
and stored at -20°C. For the described treatments, the complete culture medium was supplemented 
with PL reaching the final concentration of 5% (v/v), approximately corresponding to the highest 
physiological concentration of platelets in the human blood, without adding heparin. 
3.2.3. Primary hASC cultures 
Primary human adipose-derived stromal cell (hASC) cultures were obtained from subcutaneous 
adipose tissue liposuction wastes derived from healthy female donors. All donors provided the 
written informed consent. Protocol and procedures were approved by the Local Ethical Committee. 
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The hASCs were isolated following the protocol reported by Estes, Diekman, Gimble, & Guilak, 
2010, with some modifications. Briefly, liposuction aspirate was extensively washed with 
phosphate-buffered saline (PBS, composed by 136.9 mM NaCl, 2.7 mM KCl, 8.0 mM Na2HPO4, 
1.5 mM KH2PO4, with pH 7.4) (1:1 volume). After that, the fat sample was digested with 0.1% type 
I collagenase in PBS (1:1 volume) at 37°C for 1h shaking the mix by hand every 5-10 minutes. The 
digested sample was centrifuged at 290g for 5 minutes at room temperature and, at the end of 
centrifugation, shacked vigorously to ensure all the stromal cells could be properly released and 
separated from the remaining tissue. After a further centrifugation, the upper mature adipocyte and 
middle collagenase/PBS layers were aspirated off leaving the pellet, which were composed by the 
stromal vascular fraction (SVF). The pellet was re-suspended in αMEM supplemented with 10% 
(v/v) FBS, 100 U/mL penicillin G and 100 µg/mL streptomycin sulphate for neutralizing the 
residual collagenase. The SVF was centrifuged, re-suspended in PBS and splitted in two half. After 
a final centrifugation, one half was re-suspended with a volume of αMEM supplemented with 10% 
(v/v) HS, 100 U/mL penicillin G and 100 µg/mL streptomycin sulphate (complete medium) 
corresponding to half of initial volume of lipoaspirate, while the other half with an identical volume 
of αMEM supplemented with 10% (v/v) FBS, 100 U/mL penicillin G and 100 µg/mL streptomycin 
sulphate (control medium). The SVF cells were plated at an equivalent to about 0,04 mL of 
liposuction aspirate per cm2 for every condition. Adhering hASC cultures were incubated at 37°C in 
a humidified atmosphere with 5% CO2 and media were changed 3 times per week. At 80% 
confluence, cells were harvested by trypsinization and frozen in liquid nitrogen using αMEM 
supplemented with 50% (v/v) HS or FBS, 10% (v/v) DMSO, 100 U/mL penicillin G and 100 
µg/mL streptomycin sulphate for long-term storage (passage 0, P0). After to be thawed, cells were 
expanded for one passage (P1) and used at passage 2 (P2) for all the described experiments, except 
for CFE assay and differentiation assays of PL-expanded cells. In particular, for differentiation 
assays of PL-expanded cells, HS-isolated hASCs were expanded for one passage with complete 
medium and for further 3 passages with complete medium supplemented with 5% PL and used at 
passage 5 (P5). 
3.2.4. In toto hAT cultures 
In toto human adipose tissue (hAT) samples were obtained from resection material of 
abdominoplasty on healthy female donors. All donors provided the written informed consent. The 
inner portion of subcutaneous fat was minced into pieces with the diameter of 3-4 mm, paying 
attention to avoid visible blood vessels. Such pieces were cultured in complete culture medium 
supplemented with 5% PL, 100 U/mL IL-1α, or 5% PL + 100 U/mL IL-1α, or without any 
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supplement, for 14 days. In toto hAT cultures were incubated at 37°C in a humidified atmosphere 
with 5% CO2 and media were changed 3 times per week. 
3.2.5. Proliferation assays 
I. Cell counting: HS- and FBS-isolated hASCs at P2 were plated at 4157 cells/cm2/well in 6-
well plates using the complete or control culture medium according to their isolation 
condition. They were incubated for 24h to enable cell adhesion to wells and, the next day 
(day 0), medium was replaced with complete medium, un-supplemented or supplemented 
with 5% PL, or control medium. For each culture condition, the cell number was measured 
in two different wells, after 0, 2, 4, 6 and 8 days of stimulation, using a Bright-Line™ 
Hemacytometer with an improved Neubauer chamber. The final result was expressed as the 
average of 3 independent experiments performed on different single-donor primary hASC 
cultures ± SD value.  
II. Crystal violet staining assay: HS-isolated hASCs were plated at 2.5x103 cells/well in 96-
well plate and incubated in complete medium for 24h. The next day (day 0), medium was 
replaced with complete medium un-supplemented or supplemented with 5% PL, 100 U/mL 
IL-1α, or 5% PL + 100 U/mL IL-1α. Crystal violet staining assay was performed in 
quintuplicate for each culture condition after 0, 1, 2, 3 and 4 days of the different 
stimulations. At every time point, the culture media were removed and replaced with 50 
µL/well of 0.75% (w/v) crystal violet staining solution (prepared using 0.375 g crystal violet 
powder, 0.175 g NaCl, 16.15 mL absolute ethanol and 4.32 mL formaldehyde 37% weight 
solution and bringing to 50 mL with distilled water). After 20-minute incubation, the 
staining solution was discarded and wells were extensively washed with distilled water. 
When the plates were dry, 100 µL/well of elution solution (composed by 50% v/v absolute 
ethanol and 1% v/v acetic acid in PBS) was added. For each well, the optical density (OD) 
was measured at 595 nm. As final result, it was reported the n-fold increase of OD respect to 
day 0, for each culture condition, expressed as the average of 3 independent experiments 
performed on different single-donor primary hASC cultures ± SD value. 
3.2.6. Viability assay 
The hASC viability under the same culture conditions assayed with the cell counting was evaluated 
in a parallel set of experiments by colorimetric MTT assay. This assay is based on the reduction of 
MTT, a yellow water-soluble substrate, in formazan, a blue alcohol-soluble reaction product, by 
mitochondrial succinate dehydrogenase of living cells. Formazan is then dissolved in alcohol and 
spectrophotometrically measured. Therefore, the optical density (OD) is strictly correlated with 
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viable cell number. In particular, HS- or FBS-isolated hASCs at P2 were plated at 4157 
cells/cm2/well in 24-well plates and, after an incubation of 24h, medium was replaced with 
complete medium, un-supplemented or supplemented with 5% PL, or control medium, respectively. 
After 0, 2, 4, 6 and 8 days of stimulation, cell layers were incubated with 5 mg/mL MTT in serum-
free medium for 3h at 37°C in a humidified atmosphere with 5% CO2 in the dark. The MTT 
solution was then removed and formazan was dissolved in absolute ethanol. The OD of the 
resulting solution was measured using a test wavelength of 570 nm and a reference wavelength of 
670 nm. For each culture condition, the OD was measured in three different wells and expressed as 
the average of 3 independent experiments performed on different single-donor primary hASC 
cultures ± SD value. 
3.2.7. Colony-forming efficiency assay 
Immediately after their isolation (P0), hASCs were plated at 100 µL of lipoaspirate/Petri dish in 
complete medium, un-supplemented or supplemented with 5% PL, or in control medium in 
duplicate per each culture condition. After 9 days, colonies were fixed by 10% neutral buffered 
formalin (comprised of 10 mL formaldehyde 37% weight solution, 90 mL PBS) for 10 min at room 
temperature and stained with 1% methylene blue solution at pH 8.8 (prepared with 1% w/v 
methylene blue hydrate powder, 0.2 M boric acid, 0.05 M sodium tetraborate decahydrate, distilled 
water up to the final volume) for 45 min at room temperature. The dye excess was washed away 
with distilled water and dishes were allowed to air dry. In each dish, the colony number was 
counted by naked eye. The CFE was also quantified by using the ImageJ-plugin “ColonyArea”, 
which calculates two output parameters: ‘colony area percentage’, i.e. the percentage of dish area 
covered by colonies, and ‘colony intensity percentage’ that takes into account both the area covered 
by colonies and the density of the colonies (Guzmán, Bagga, Kaur, Westermarck, & Abankwa, 
2014). The number of colonies/condition and both the ColonyArea-derived parameters were 
expressed as mean values ± SD calculated on the basis of 5 independent experiments relative to 
different single-donor primary cultures for all tested culture conditions.  
3.2.8. Adipogenic and osteogenic differentiation 
To induce adipogenic and osteogenic differentiation, HS-isolated hASCs at P2 or PL-expanded 
hASCs at P5 were plated at 8314 cells/cm2/well in 24-well plates and were expanded for at least 4 
days in complete medium. After this expansion step, one half of sub-confluent cell wells was 
treated with specific induction media for adipogenic and osteogenic differentiation for 14 days and 
the other half was cultured with complete medium as control. Adipogenic differentiation medium 
was composed by complete medium supplemented with 6 ng/mL insulin and 10-7 M dexamethasone 
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(Scott, Nguyen, Levi, & James, 2011). Osteogenic differentiation medium was composed by 
complete medium supplemented with 50 µg/mL ascorbic acid, 10 mM β-glycerophosphate and 10-7 
M dexamethasone (Muraglia et al., 2017). The media were changed 3 times per week. At day 14, 
the presence of intracellular lipid droplets was detected in all the cell cultures induced to 
adipogenesis and in half of those induced to osteogenesis, with their relative control cultures, by Oil 
Red O (ORO) staining. Cell layers were fixed with a formol-calcium solution (comprised of 10 mL 
formaldehyde 37% weight solution, 1 g calcium chloride, 90 mL distilled water) for 10 min at room 
temperature. They were extensively washed with distilled water and stained with 0,5% (w/v) ORO 
in propan-2-ol, diluted 3:2 in distilled water, for 20 min at room temperature. The dye excess was 
washed away with distilled water and photos of stained cell layers were taken by Hamamatsu Color 
Chilled 3CCD Camera C5810. For adipogenic induction experiment, incorporated ORO was 
extracted by incubating stained cell layers in 100% propan-2-ol for 10 min at room temperature 
with mild agitation. For control and induction conditions, the optical density (OD) was measured at 
530 nm in triplicate and expressed as the average of 3 independent experiments performed on 
different single-donor primary hASC cultures ± SD value. Analogously, the amount of incorporated 
ORO was also evaluated in hASCs plated at P2 at 4157 cells/cm2/well in 24-well plates and 
cultured in complete medium, un-supplemented or supplemented with 5% PL, or in control medium 
for 0, 4 and 8 days, without any induction. The final result is expressed as means ± SD values 
considering at least 3 independent experiments assayed in triplicate on different single-donor 
primary cultures. At the end of osteogenic induction, the matrix mineralization in the induced 
cultures was valuated by Alizarin Red S (ARS) staining. Cell layers were fixed with 4% (w/v) 
paraformaldehyde in PBS for 10 min at room temperature. They were washed with distilled water 
and stained with 2% (w/v) ARS in distilled water at pH 4.2 for 10 min at room temperature. After a 
washing step with absolute ethanol and others with distilled water, the stained wells were allowed 
to air dry and finally scanned by Epson Perfection V330 Photo Scanner. The osteogenic 
differentiation was assayed in duplicate on 3 different single-donor primary cultures. 
3.2.9. Real Time quantitative PCR analysis 
To analyse the expression of adipogenesis-related genes, total RNA was extracted from HS- and 
FBS-cultured hASCs used for cell counting experiment at 0, 4 and 8 culture days and from HS-
cultured cells stimulated with 5% PL for 4 days by RNeasy® Plus Micro Kit following 
manufacturer’s instructions. Total RNA concentrations were measured at 260 nm and total RNA 
purity was checked considering 260 nm/280 nm ratio with values included in 1.9-2.1 range. Total 
RNA was reverse-transcribed to cDNA using Omniscript® RT Kit according to manufacturer’s 
protocol. Transcript levels of target genes were measured by Real Time quantitative PCR using 
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Power SYBR® Green PCR Master Mix on 7500 Fast Real-Time PCR System. Primer sequences 
were: forward 5’-CCTATTGACCCAGAAAGCGA-3’ and reverse 5’-
GGGAGTGGTCTTCCATTACG-3’ for PPARγ2 (designed by Primer-BLAST, Ye et al., 2012); 
forward 5’-CAGAGGGACCGGAGTTATGA-3’ and reverse 5’-TTCACATTGCACAAGGCACT-
3’ for C/EBPα (Russo, Yu, Belliveau, Hamilton, & Flynn, 2014); forward 5’-
GACTCAACACGGGAAACCTCACC-3’ and reverse 5’-ACCAGACAAATCGCTCCACCAACT-
3’ for 18S rRNA (Schiller, Schiele, Sims, Lee, & Kuo, 2013). The expression of 18S rRNA was 
used as endogenous control (normalizer). For each primer pair, the production of single amplicon 
was checked by generating a melting curve. Transcript levels were extrapolated from a standard 
curve, generated using a dilution series of all total RNA sample mixture, and divided by normalizer 
quantity. Each sample was assayed in triplicate. The final results are expressed as the average of 3 
independent experiments performed on different single-donor primary hASC cultures ± SD values. 
3.2.10. Western blot analysis  
To analyse the cytokine production, HS-isolated hASCs at P2 were seeded in 60 mm dishes, 
cultured in complete medium until 80% confluence and treated for 24h with serum-free medium 
supplemented with 5% PL, 100 U/mL IL-1α, or 5% PL + 100 U/mL IL-1α, or without any 
supplement. Cells were then extensively washed with PBS for removing residual factors and then 
incubated in serum-free medium for 24h. The different media were collected, clarified at 2000 rpm 
for 10 min at room temperature and stored at -20°C. The incubation in serum-free medium for 24h 
and the collection of conditioned media were consecutively repeated twice more on the same cell 
layers obtaining media at 48h and 72h. To investigate the activation of inflammation-related 
pathways, HS-isolated hASCs were treated as described above and, at the end of 24h stimulation, 
cells were extensively washed with PBS and lysed by incubating the cell layers on ice for 5 min 
with ice-cold RIPA buffer (containing 50 mM Tris HCl pH 7.5, 150 mM NaCl, 1% w/v sodium 
deoxycholate, 1% v/v Triton X-100, 0.1% w/v sodium dodecyl sulphate and 0.2% w/v sodium 
azide) supplemented with protease inhibitor cocktail. Cell lysates were harvested with cell scrapers, 
clarified at 10000 rpm for 15 min at 4°C and stored at -20°C. The same procedure was followed for 
preparing cell lysates corresponding to cell layers used for collecting conditioned media at 72h. To 
study the PL effect on proliferation-related pathways and on cell cycle activation, sub-confluent 
HS-isolated hASCs were incubated in serum-free medium for 1h (serum starvation) and treated for 
multiple time intervals with serum-free medium supplemented with 5% PL. Cells were washed with 
cold PBS on ice and incubated at -80°C for at least 1h. Cell layers were then incubated on ice with 
ice-cold RIPA buffer supplemented with protease inhibitor cocktail, immediately harvested with 
ice-cold cell scraper, clarified at 10000 rpm for 15 min at 4°C and stored at -20°C. The protein 
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content of both conditioned media and cell lysates was quantified by Bradford protein assay 
(Bradford, 1976). Electrophoresis was performed in reducing conditions using 6 µg of total 
protein/sample for conditioned media and 30 µg or 100 µg for cell lysates for studying 
inflammation-related or proliferation-related pathways, respectively. Proteins were loaded on 
NuPAGETM 4-12% Bis-Tris gel and transferred to AmershamTM ProtranTM 0.45 µm NC 
nitrocellulose blotting membrane. The blot was saturated with 5% skimmed cow milk in TTBS 
(composed by 20 mM Tris HCl pH 7.5, 500 mM NaCl and 0.1% Tween 20 in distilled water) for 2h 
at room temperature and probed in a cold room overnight with primary antibodies raised against IL-
8 (1:250 dilution) and IL-6 (1:250 dilution) for conditioned media or against COX-2 (1:1000 
dilution), mPGES-1 (1:200 dilution), phospho-Akt (1:1000 dilution), Akt (1:1000 dilution), 
phospho-ERK1/2 (1:1000 dilution), ERK1/2 (1:1000 dilution), Cyclin D1 (1:250 dilution), phospho-
STAT3 (1:1000 dilution) and Actin (1:500 dilution) for cell lysates. After washing, the detection 
was obtained by incubating the blot with specific secondary horseradish peroxidase-linked IgGs 
(1:6000 dilution) for 1h at room temperature. The blot was then washed with TTBS, incubated with 
AmershamTM ECLTM western blotting detection reagents following manufacturer’s instructions and 
finally exposed to AmershamTM hyperfilmTM ECL to capture the image. For each considered 
marker, western blot was performed on 3 independent experiments corresponding to different 
single-donor primary hASC cultures. The densitometric analysis for IL-6 and IL-8 secretion and for 
Cyclin D1 synthesis was performed by scanning the relative films using Epson Perfection V330 
Photo scanner (Epson, Italy) and quantifying the band densities using ImageJ software 
(https://imagej.nih.gov/ij/download.html). The relative shown results are the average of 3 
independent experiments ± SD values. 
3.2.11. PGE2 quantification 
For the quantification of PGE2 in conditioned media, Prostaglandin E2 ELISA kit was used. This 
assay is based on the competition between PGE2 present in the sample and a PGE2-
acetylcholinesterase (AChE) conjugate (PGE2-tracer) for a limited amount of anti-PGE2 
monoclonal antibody. By adding the substrate of AChE, a colorimetric reaction occurs and the 
relative absorbance is measured spectrophotometrically at 405 nm. The PGE2 concentration relative 
to the sample is calculated using a standard curve. The hASC 24h,72h-conditioned media were 
prepared in the same way reported for western blot analysis and assayed following manufacturer’s 
instructions. For each culture condition, the PGE2 concentration is reported as average value of 3 
independent experiments performed in duplicate on different single-donor primary cultures ± SD. 
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3.2.12. Histological analysis 
After 14 culture days, in toto hAT samples were fixed with a formol-calcium solution overnight at 
4°C, rinsed extensively with PBS, dehydrated with increasing ethanol concentrations, cleared in 
xylol and embedded in paraffin. As control, some in toto hAT pieces were fixed and paraffin-
embedded immediately after their isolation from the resection material (un-stimulated hAT). All 
samples were cut into sections of 5 µm, which were placed on poly-L-lysine-coated glasses and 
dried overnight at 37°C. Sectioned samples were stained with Hematoxylin and Eosin (H&E). For 
immunohistochemical investigations, sections were deparaffinised, hydrated to water with 
decreasing ethanol concentrations, incubated with 0.2% Triton in PBS for 10 min to permeabilize 
cell membranes, incubated with 0.3% H2O2 in distilled water for 30 min to block endogenous 
peroxidase activity and covered with 10% normal goat serum in PBS for 1h to reduce non-specific 
staining. Sections were incubated with primary antibody raised against PCNA (1:200 dilution) 
diluted in 5% normal goat serum in PBS overnight at 4°C in a humid chamber. As negative control, 
one section per slide was incubated only with 5% normal goat serum in PBS. For detection of 
primary antibody, sections were incubated first with biotinylated IgGs (1:200 dilution), diluted in 
5% normal goat serum in PBS, and then with streptavidin-peroxidase (1:500 dilution), diluted in 
5% normal goat serum in PBS, each for 30 min at room temperature. The peroxidase was visualized 
using DAB following manufacturer’s instructions. A complete histological analysis was performed 
on each of 3 different single-donor hAT samples.    
3.2.13. Statistical analysis  
All data are presented as means and standard deviations based on independent experiments 
performed on at least three different primary hASC cultures, each of them derived from a single 
donor. The statistical analysis was performed using the unpaired t-Test for cell counting assay, real 
time quantitative PCR analysis, CFE assay and ORO quantification or using the ordinary one-way 
ANOVA for IL-8, IL-6 and Cyclin D1 densitometric analysis, PGE2 quantification and crystal 
violet assay. If ANOVA detected statistically significant differences within the data set, Tukey’s 
multiple comparison test was used to calculate the significant differences for IL-8 and IL-6 
densitometric analyses, PGE2 quantification and crystal violet assay. Dunnett’s multiple comparison 
test was used for Cyclin D1 densitometric analysis. All tests were run setting a confidence interval 
of 95% (p<0,05). 
	 52 
3.3. Results 
3.3.1. HS sustains hASC proliferation more efficiently than FBS 
Since our attempt was to study in vitro the cell behaviour in the wound microenvironment, primary 
hASCs were isolated in presence of HS, which was devoid of platelet-derived factors, and 
characterized respect to cells isolated with FBS. In particular, the cells were isolated using a culture 
medium supplemented with 10% HS or 10% FBS (complete or control medium, respectively) and 
were frozen in liquid nitrogen at P0 for long-term storage. After thawing, (92.8±8.1)% and 
(88.6±9.6)% of viable cells were obtained with complete and control medium, respectively, by 
trypan blue exclusion test. The proliferation of HS- and FBS-expanded hASCs was monitored at P2 
for 8 days by cell counting. The HS-expanded hASCs had a higher proliferation rate respect to 
FBS-expanded cells, showing a significant (5.75±1.35)-fold increase of cell density after 8 culture 
days (Figure 1a, p=0.0006 for 10%FBS vs. 10%HS at day 8). In parallel experiments, we evaluated 
cell viability in the same conditions used for cell counting by MTT assay, obtaining trends similar 
to those relative to cell proliferation (Figure 1b). This finding indicates that hASCs were 
metabolically active independently from the cell density. Cell morphology was different depending 
on culture conditions (Figure 1c). In agreement with the reported cell density, HS-expanded hASCs 
were smaller than FBS-expanded cells, which showed a spreading and flatter shape.  
Although HS sustained cell proliferation more efficiently than FBS, we did not find a significant 
difference in the number of colony-forming unit-fibroblasts (CFU-fs) between complete and control 
medium by CFE assay (Figure 1d,e). For the quantitative analysis of CFE assay, we used the 
ImageJ-plugin “ColonyArea”, which calculates the percentage of dish area covered by colonies 
(colony area percentage) and the intensity-weighted area percentage (colony intensity percentage). 
Both the output parameters increased with the complete medium respect to the control one but these 
differences were not significant (Figure 1f). 
3.3.2. HS induces spontaneous adipogenic differentiation in hASCs 
During hASC culture in presence of HS, we observed spherical deposits within the cells increasing 
in number and dimension with time while they were absent in hASCs cultured with FBS. The ORO 
staining of hASCs at P2 cultured with 10% HS for 0, 4 and 8 days showed ORO-positive cells with 
red-stained lipid deposits increasing with time while FBS-expanded hASCs were totally negative 
(Figure 2a,b). Quantitation of the amount of incorporated ORO, normalized per cell number, 
showed a trend of increase with time in agreement with the observation of the progressive increase 
of deposits (Figure 2c), suggesting the spontaneous differentiation of ASCs towards adipogenesis. 
Analysis of total RNA extracted from hASCs cultured with HS and FBS for 0, 4 and 8 days showed 
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that transcript levels of pparγ2 and c/ebpα, two master regulators of adipogenesis, gradually 
increased with time in HS-expanded hASCs at variance with FBS-expanded cells in which they 
remained at a basal level with time (Figure 2d,e). At 8th day, pparγ2 and c/ebpα expression reached 
a level significantly higher in HS-cultured cells with respect to FBS-cultured ones (p=0.0422 and 
p=0.0318 for 10%HS vs. 10%FBS, respectively).  
3.3.3. Committed HS-expanded hASCs differentiate towards adipogenesis and osteogenesis 
From observing HS-expanded hASC cultures after ORO staining, we realized that cell layers 
contained some regions with ORO-negative cells also at high cell density after 8 culture days. For 
this reason, we induced committed HS-expanded hASCs to differentiate into the adipogenic lineage 
in order to investigate qualitatively the capability of ORO-negative cells to differentiate towards 
adipogenesis. Sub-confluent hASCs at P2 were treated with complete medium supplemented with 6 
ng/mL insulin and 10-7 M dexamethasone or un-supplemented (control) for 14 days obtaining in 
induced cultures ORO-positive cells with intracellular lipid droplets morphologically similar to 
those recognised in control cultures at the end of induction (Figure 3a). The amount of 
incorporated ORO in the treated cells did not significantly vary between induced and control 
cultures although a trend of increase was shown (Figure 3b). However, we still found several 
ORO-negative cells in induced cell layers.  
To verify the presence of immature or less committed cells in HS-expanded hASC cultures, we 
induced the osteogenic differentiation in sub-confluent HS-expanded hASCs containing lipid 
droplets at P2 by using complete medium supplemented with 50 µg/mL ascorbic acid, 10 mM β-
glycerophosphate and 10-7 M dexamethasone or un-supplemented (control) for 14 days. At the end 
of induction, ARS staining revealed a great amount of calcium-rich deposits in the extracellular 
matrix of induced cells but not in the control cultures (Figure 3c). In a parallel set of experiments, 
we still found ORO-stained lipid droplets within induced ASCs. Surprisingly, these droplets were 
qualitatively very similar to those found in the control cultures (Figure 1Sa,b). Interestingly, when 
chondrogenic differentiation was induced on HS-expanded hASCs at P2 by pellet-culture method 
using serum-free medium supplemented with 6.25 µg/mL insulin, 6.25 µg/mL human apo-
transferrin, 1.25 µg/mL linoleic acid, 5.35 µg/mL bovine serum albumin, 1 mM sodium pyruvate, 
50 µg/mL ascorbic acid, 10-7 M dexamethasone and 10 ng/mL TGF-β1 for 21 days, poor 
metachromatic toluidine blue staining and no collagen type II production were detected in the 
extracellular matrix of pellets by histological analysis (Figure 2Sa,b).  
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3.3.4. Proliferation in the wound microenvironment: PL increases the proliferation of HS-
expanded hASCs 
Considering that platelets release a cocktail of bioactive molecules by degranulation as soon as an 
injury occurs, we evaluated the effect of PL, possibly representing the content released by platelets, 
on the proliferation of hASCs isolated and cultured in HS in order to mimic the wound 
microenvironment. Cell proliferation and viability were determined in HS-expanded cells at P2 
stimulated with 5% PL by cell counting and MTT, respectively. The presence of PL in the complete 
medium induced a significant increase of cell proliferation and, at the same time, a similar increase 
of cell viability, revealing that proliferating cells were metabolically active (Figure 4a,b, p=0.0004 
for 10%HS+5%PL vs. 10%HS at day 4). After 4 days of PL treatment, cell density in presence of 
PL was (2.76±0.58)-fold higher than that reached in absence of PL. At longer time, confluent hASC 
layers detached starting from borders forming each a spheroidal cell mass. The PL treatment 
determined spindle-like morphology and smaller dimensions compared to cells cultured in the 
absence of PL (Figure 4c). Interestingly, the differences in cell morphology were evident 
immediately after the cultures were established. 	
In presence of PL, the number of CFU-fs did not significantly vary compared to un-supplemented 
culture condition (Figure 4d,e). Instead, colony area percentage and colony intensity percentage, 
calculated by ImageJ-plugin “ColonyArea”, were significantly higher when PL was added to 
complete medium respect to the values recovered for the un-supplemented condition (p=0.0001 for 
10%HS vs. 10%HS+5%PL regarding colony area percentage; p<0.0001 for 10%HS vs. 
10%HS+5%PL regarding colony intensity percentage) (Figure 4f). 
3.3.5. PL activates Akt, ERK and STAT3 pathways and induces Cyclin D1 synthesis in 
hASCs 
Starting from the findings about the strong increase of proliferation rate induced by PL treatment, 
we focused our attention on the PL effect on three common proliferation-related pathways and on 
cell cycle activation. In particular, sub-confluent HS-isolated hASCs were serum starved for 1h in 
order to reduce cell metabolism and treated for multiple time intervals with serum-free medium 
supplemented with 5% PL. At the end of stimulation, cell layers were harvested and analysed by 
western blot. We found a strong and transient activation of Akt and ERK pathways by 
phosphorylation starting from 30 min of PL stimulation and decreasing after 1h. The activation of 
STAT3 pathway was gradual starting from 30 min and arriving to 24h of PL treatment 
corresponding to the maximum level of phospho-STAT3 (Figure 5a). We revealed an analogous 
activation of these three pathways also in cell lysates derived from sub-confluent HS-isolated 
hASCs treated with PL in presence of HS (data not shown). Regarding cell cycle activation, PL 
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induced a significant increase of Cyclin D1 after 4h of treatment (p=0.0009 for 0h vs. 4h) reaching 
a level (3.43±0.92)-fold higher than basal level. After that, Cyclin D1 decreased at 8h (p=0.0065 for 
0h vs. 8h) and disappeared at 24h (Figure 5b). An analogous trend in the Cyclin D1 synthesis was 
observed when hASCs were treated with PL in presence of HS (data not shown).  
3.3.6. PL-activated hASCs retain differentiation capability towards adipogenesis and 
osteogenesis  
Since HS-expanded hASCs showed spontaneous adipogenic differentiation and further increased 
adipogenesis in permissive conditions, we studied the capability to differentiate of PL-activated 
cells. The HS-expanded hASCs at P2 stimulated with 5% PL for 4 days retained the capability to 
differentiate spontaneously towards adipogenesis, as shown by ORO staining, but the quantitation 
of incorporated ORO, referred to the ratio between the cell number in PL-supplemented complete 
medium and the cell number in complete medium, showed a significant decrease in PL-treated cells 
(Figure 6a,b, p=0.0230 for 10%HS vs. 10%HS+5%PL). At the same time, we also found a 
significant decrease of pparγ2 transcript level in PL-treated cells respect to un-treated cells (Figure 
6c, p=0.0024 for 10%HS vs. 10%HS+5%PL).  
Moreover, we expanded HS-isolated hASCs with complete medium supplemented with 5% PL for 
further 3 passages and induced them to differentiate towards adipogenesis and osteogenesis. Sub-
confluent PL-expanded hASCs at P5 were treated with complete medium supplemented with 6 
ng/mL insulin and 10-7 M dexamethasone or un-supplemented (control) for 14 days, obtaining in 
the induced cultures ORO-positive cells with intracellular lipid droplets morphologically similar but 
of greater dimensions respect to those recognised in the control cultures at the end of induction 
(Figure 7a). Regarding osteogenic differentiation, sub-confluent PL-expanded hASCs at P5 were 
treated with complete medium supplemented with 50 µg/mL ascorbic acid, 10 mM β-
glycerophosphate and 10-7 M dexamethasone or un-supplemented (control) for 14 days. At the end 
of induction, ARS staining demonstrated the capability of these cells to produce a mineralized 
extracellular matrix in response to permissive conditions (Figure 7b). In a parallel set of 
experiments, we found ORO-positive lipid droplets within osteogensis-induced hASCs even though 
they were fewer and smaller respect to those present in the control condition (Figure 3Sa,b). 
3.3.7. PL exerts the mitogenic effect in both physiological and inflammatory milieu 
Having in mind that the recruitment of stem/progenitor cells out from their tissue niche takes place 
in inflammatory milieu at the wound site, we investigated the PL effect on hASC growth under both 
physiological and inflammatory conditions. The HS-expanded hASCs were treated with complete 
medium un-supplemented or supplemented with 5% PL, 100 U/mL IL-1α, or 5% PL + 100 U/mL 
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IL-1α for multiple times and the cell proliferation was monitored by crystal violet staining. We 
found that PL significantly increased cell proliferation respect to reference condition in 
physiological milieu in agreement with the results obtained with cell counting (p=0.0024 for 
10%HS vs. 10%HS+5%PL at 4th treatment day). Regarding inflammatory milieu, PL significantly 
induced an increase of the proliferation rate respect to reference condition (p=0.0445 for 
10%HS+100U/mLIL-1α vs. 10%HS+5%PL+100 U/mLIL-1α at 4th treatment day). No significant 
differences were detected between HS+PL and HS+PL+IL-1α conditions or between HS and 
HS+IL1α (Figure 8a,b).  
3.3.8. PL induces a transient pro-inflammatory response in HS-expanded hASCs in 
inflammatory milieu 
Considering that platelet content is not only involved in the proliferative response of resident cells 
but also in triggering and modulating the inflammatory state at the wound site, we investigated the 
PL effect on the inflammatory response of hASCs in both physiological and inflammatory 
condition. For this reason, sub-confluent HS-expanded hASCs were treated for 24h with serum-free 
medium supplemented or not with 5% PL for physiological conditions and supplemented with 100 
U/mL IL-1α and/or 5% PL for inflammatory conditions. At the end of stimulation, the media were 
replaced every 24h with serum-free medium collecting conditioned media at 24, 48 and 72h. By 
western blot analysis of conditioned media, we found a significantly increased secretion of pro-
inflammatory cytokines IL-6 and IL-8 with PL+IL-1α respect to IL-1α at 24h of serum-free 
incubation (p<0.0001 and p=0.0002 for 100U/mLIL-1α vs. 5%PL+100U/mLIL-1α at 24h regarding 
IL-6 and IL-8, respectively). Their secretion in PL+IL-1α gradually decreased up to basal level after 
72h of serum-free incubation (p<0.0001 and p=0.0002 for 24h vs. 72h of 5%PL+100U/mLIL-1α 
regarding IL-6 and IL-8, respectively) (Figure 9a). Moreover, cell lysates were harvested at the end 
of 24h stimulation and after 72h of incubation with serum-free medium. By western blot analysis, 
we observed a strongly increased production of COX-2 after 24h of PL and IL-1α treatment and the 
complete disappearance of the signal after 72h of serum-free incubation. Regarding mPGES-1 
production, we revealed a remarkable basal level enhanced by PL in both physiological and 
inflammatory condition after 24h treatment. After serum-free incubation, mPGES-1 level increased 
with all tested conditions (Figure 9b). As a consequence of COX-2 and mPGES-1 induction, we 
found a significantly increased concentration of PGE2 with PL+IL-1α respect to IL-1α (p=0.0029) 
as regards 24h conditioned media by ELISA analysis, indicating a synergistic activity of IL-1α and 
PL in hASCs. After 72h serum-free incubation, PGE2 levels with PL+IL-1α decreased reaching the 
basal level (p=0.0060) (Figure 9c). 
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3.3.9. PL induces cell proliferation also in in toto hAT cultured ex vivo 
To confirm in vitro results obtained with hASCs, we decided to culture ex vivo in toto hAT samples 
using complete medium supplemented with 5% PL, 100 U/mL IL-1α, or 5% PL + 100 U/mL IL-1α, 
or without any supplement, for 14 days. During the culture, we did not revealed any change of hAT 
morphology and colour in all tested conditions. We observed spindle-like cells to come out, adhere 
to plastic and proliferate in all conditions, especially under PL stimulation (Figure 10). After 14 
culture days, every hAT piece was collected, paraffin-embedded and examined by histological 
analysis. In particular, H&E staining revealed the presence of small and elongated cells in the outer 
layer of the pieces in every tested condition, especially with PL (Figure 11a). Moreover, the 
immunohistochemical analysis with specific antibody directed against the proliferation marker 
PCNA demonstrated small outlying cells were actively proliferating (Figure 11b). This outcome 
indicates that PL is able to exert the mitogenic effect, observed already with hASC culture, also in 
in toto hAT.	
3.4. Discussion 
Wound-healing process consists of a sequence of finely orchestrated events leading to the repair of 
the damaged tissue. When the progression of this process is impaired, chronic (or acute) wounds 
take place, especially in patients with underlying pathologies, affecting millions people around the 
world. The failure of the wounds to heal is largely related to vascular insufficiency, diabetes 
mellitus and local excessive pressure (Demidova-Rice, Hamblin, & Herman, 2012). Our interest is 
focused on the molecular basis of the wound-healing process in order to identify the endogenous 
pathways naturally activated following the injury and envisage a therapeutic approach able to re-
order the impaired process of the chronic wounds. Starting from the previous findings obtained 
investigating the platelet lysate effects on human keratinocytes (El Backly et al., 2011), we studied 
the response of human subcutaneous adipose tissue to platelet-derived factors under conditions 
mimicking as much as possible the wound microenvironment in order to evaluate its contribute in 
supporting the repair process of skin lesions. For this purpose, we defined a clinically relevant 
model using Human Serum (HS), Platelet Lysate (PL) and Interleukin-1α (IL-1α) as effectors and 
primary human adipose-derived stromal cells (hASCs) and in toto human adipose tissue (hAT) 
cultured ex vivo as targets. Considering the manufacturing procedures of the used supplements, it is 
necessary to make some considerations of HS and PL composition. In particular, HS was un-
contaminated by platelet-derived factors, as Muraglia et al. (2017) already reported. Analogously, 
the PL did not contain any plasmatic molecule since it has been prepared using platelets extensively 
washed with physiological saline before to have been disrupted. Consequently, such supplements 
allowed us to study rigorously their separated and combined effects on adipose tissue. 
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Considering that serum is the physiologic fluid present at the wound site following the coagulation 
process, we first evaluated the effect of HS on in vitro proliferation and differentiation of hASCs in 
comparison with FBS, normally used as gold standard for hASC culture. In particular, we found 
that HS sustained hASC proliferation with a rate significantly higher than FBS in agreement with 
data reported in literature (Hui et al., 2012; Kocaoemer, Kern, Klüter, & Bieback, 2007; Witzeneder 
et al., 2013). However, no statistically significant difference was observed in the number of isolated 
CFU-fs between HS and FBS, in agreement with Kocaoemer et al. (2007), demonstrating that the 
increased proliferation induced by HS was not related to a greater number of clonogenic progenitor 
cells. Moreover, we found that HS allowed adipogenic programme to carry on in hASCs by 
inducing the expression of two master regulators of adipogenesis PPARγ2 and C/EBPα and the 
accumulation of lipid droplets within the cells while no induction was observed with FBS. This 
finding was not previously reported in studies on cell differentiation in presence of human serum 
(Kocaoemer et al., 2007; Lindroos et al., 2010), possibly because such studies were performed 
using serum prepared from total blood instead of serum from plasma devoid of platelets, but it is in 
agreement with Hui et al. (2012) showing that HS decreased the expression of stemness-related 
genes although proliferation was induced. Considering both the morphology and the amount of 
incorporated lipid droplets, the HS-induced adipogenesis showed to be qualitatively similar to 
adipogenesis obtained following a traditional differentiation protocol normally used for hASCs 
cultured in FBS (Scott et al., 2011). By promoting the osteogenic differentiation with a traditional 
protocol (Muraglia et al., 2017), we obtained a strong deposition of mineralized matrix by HS-
committed hASCs even though lipid droplets were still revealed within cells by ORO staining, as 
also reported by Lindroos et al. (2010). These findings suggest HS-expanded hASCs could 
represent a heterogeneous cell population constituted by progenitor cells at different stages of 
commitment. In this scenario, we speculate that in presence of human plasmatic molecules more 
committed cells would be able to continue their adipogenic cell fate while less committed cells 
would remain immature and would respond to exogenous stimuli differentiating towards the 
osteogenic lineage, as shown above. Hypothetically, HS could exert a “niche” effect on hASCs 
regulating self-renewal and differentiation of stem/progenitor cells included in this cell population. 
Interestingly, no differentiation towards chondrogenesis was observed at variance with the reports 
in literature for hASCs expanded in FBS (Zuk, 2002), possibly because HS-expanded cells were 
more committed to adipogenesis.  
The coagulation process determines physiologically not only the conversion of plasma to serum but 
also the release of bioactive molecules from activated platelets by degranulation. For this reason, 
we studied the proliferative response of hASCs to platelet content. In particular, the presence of PL 
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in the culture medium supplemented with HS significantly enhanced cell growth reaching at 
confluence state a higher cell density and determining spindle-like morphology and smaller 
dimensions in comparison with cells cultured in the absence of PL, in agreement with an earlier 
study about bone marrow-stromal cells stimulated with PL (Chevallier et al., 2010). Under PL 
stimulation, the number of CFU-fs did not significantly vary respect to un-supplemented condition 
but PL-cultured colonies showed greater dimension and cell density than reference condition, such 
as output parameters of ImageJ-plugin “ColonyArea” revealed, in agreement with increased cell 
proliferation reported above. According to the these findings, PL determined in HS-expanded 
hASCs the early activation of proliferation-related Akt and ERK pathways, known to be involved in 
promoting cell growth (reviewed in Manning & Cantley, 2007) and implicated in the induction of 
Cyclin D1 expression and in the repression of anti-proliferative gene transcription (reviewed in 
Chambard, Lefloch, Pouysségur, & Lenormand, 2007), respectively. This outcome is supported by 
our previous study about human osteoblasts where we demonstrated the activation of such pathways 
and their involvement in cell proliferation, when PL was added to culture medium, by using Akt 
and ERK inhibitors (Ruggiu, Ulivi, Sanguineti, Cancedda, & Descalzi, 2013). In agreement with 
these findings, PL also induced the synthesis of Cyclin D1 after 4h treatment confirming the 
mitogenic role of PL in hASCs. Interestingly, we also observed that STAT3, which is involved in 
the cell-cycle progression (Hirano, Ishihara, & Hibi, 2000), was activated by PL and the maximum 
level of the phosphorylated form was reached after 24h treatment. Taken together, these data 
suggest that quiescent progenitor cells could be possibly activated and induced to proliferate by 
platelet-derived factors also at the wound site. No significant variations in hASC growth were found 
between physiological and inflammatory conditions when PL was supplemented or not to culture 
medium containing HS thus suggesting IL-1α was not involved in cell proliferation, in agreement 
with our previous study showing that human osteoblast proliferation was enhanced by adding PL to 
culture medium containing FBS, independently of the presence of IL-1α (Ruggiu et al., 2013). 
Interestingly, we observed that hASCs treated with PL for 4 days showed a significant decrease of 
incorporated ORO in parallel with a significant decrease of pparγ2 transcript level. Taken together, 
these data suggest that PL treatment would favour the presence of un-differentiated cells in cultures 
of committed hASCs. In particular, PL could possibly induce the de-differentiation of cells already 
committed in HS or induce the proliferation of un-committed cells. Moreover, we found that hASCs 
expanded in presence of PL for 3 passages retained differentiation capability towards adipogenesis 
and osteogenesis.  
In the human body, adipose tissue is not simply an inert tissue for energy storage but functions as an 
endocrine organ producing soluble mediators, indicated as adipokines, which are involved in the 
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regulation of many physiological and pathological processes (Kershaw & Flier, 2004). By using 
mouse models, Schmidt & Horsley (2013) demonstrated that mature adipocytes repopulated the 
skin wounds in parallel with fibroblast migration during the proliferative phase of healing. 
Moreover, they reported some evidences regarding a direct intercellular communication between 
adipocytes and fibroblasts that might contribute to fibroblast migration during dermal healing. 
Considering a putative role of adipogenic lineage cells in the healing of damaged skin also in 
humans, we evaluated the activation of adipogenic progenitor cells following inflammation and 
induction by platelet lysate. In particular, we investigated the secretory and inflammatory response 
of HS-expanded hASCs to PL under both normal and inflammatory conditions. We found the 
strong increase of pro-inflammatory cytokine IL-6 and IL-8 secretion from hASCs in presence of 
PL in inflammatory milieu respect to IL-1α condition, in agreement with our previously reported 
data regarding other cell systems (El Backly et al., 2011; Pereira et al., 2013; Ruggiu et al., 2013). 
Considering that the release of platelet-derived molecules is limited in time, we monitored the 
secretion of such cytokines up to 72h after the removal of PL stimulation finding the gradual 
decrease of their secretion with time. The production of COX-2, an enzyme involved in causing 
inflammation (Chen, 2010), was also temporarily induced in presence of IL-1α by a burst of PL 
(24h). As a consequence of COX-2 increase, we revealed the synergistic induction of mPGES-1 by 
PL and IL-1α even though mPGES-1 was already present at a remarkable basal level in the un-
treated cells. The mPGES-1 levels increased with time under all tested conditions, included the 
control condition. The activation of COX-2/mPGES-1 pathway by PL under inflammatory 
condition led to a massive production of PGE2, a prostaglandin able to induce the functional switch 
of macrophages towards the alternatively activated M2 phenotype, involved in the dampening of 
inflammation, as previously described in literature (Tasso et al., 2013; Vasandan et al., 2016). The 
strong but temporally transient increase of IL-6 and IL-8, already described as present in ASC 
secretome in physiological conditions and involved in wound healing (J. Braga Osorio Gomes 
Salgado et al., 2010), the transient induction of COX-2 and the production of PGE2 following PL 
treatment under inflammatory condition suggest a possible contribution in vivo of subcutaneous 
adipose tissue first in establishing an inflammatory microenvironment and then in preparing the 
inflammation resolution during body’s response to an injury. 
The ex vivo culture of in toto hAT showed that PL was able to induce the proliferation of small and 
elongated cells on the surface of hAT pieces under both physiological and inflammatory conditions, 
while the presence of such cells was limited in absence of PL. The presence of IL-1α in the culture 
medium did not influence the cell proliferation. Moreover, PL induced cells to come out from hAT 
pieces, adhere to plastic and proliferate. The nature of cells coming out from hAT pieces is under 
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investigation. Overall, these findings supported further the capability of platelet-derived factors of 
inducing in culture the cell growth not only of primary hASCs but also of in toto hATs and possibly 
in in vivo subcutaneous adipose tissue. 
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3.6. Figures & Legends 
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Figure 1: In vitro cultures of hASCs isolated and expanded in HS or FBS. a) Cell proliferation 
monitored at different times by cell counting. The average values ± SD of 3 independent 
experiments performed in duplicate on different single-donor primary cultures are reported. The 
*** symbol corresponds to p=0.0006. Statistical analysis was performed using the unpaired t-Test. 
b) Cell viability evaluated at different times by MTT assay. The average values ± SD of 3 
independent experiments performed each in triplicate are reported. c) Morphology of cells in FBS 
(left photo) and in HS (right photo) one day after the seeding (day 0). Scale bar = 50 µm. d) The 
CFE assay performed on hASCs immediately after their isolation using complete or control 
medium. Scans of dishes with methylene blue-stained colonies deriving from a representative 
experiment. e) Number of colonies per condition counted by naked eye. The average values ± SD 
are calculated referring to 5 independent experiments performed each in duplicate. f) ‘Colony area 
percentage’ and ‘colony intensity percentage’ calculated by ImageJ-plugin “ColonyArea” and 
referred to both tested condition. The average values ± SD are calculated referring to 5 independent 
experiments performed each in duplicate.  
 
Figure 2: Spontaneous adipogenic differentiation of hASCs cultured in HS with respect to FBS. 
Representative ORO staining of hASCs cultured with HS (a) or FBS (b, as control condition) with 
time. Scale bar = 50 µm. The results were confirmed performing 3 independent experiments with 
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different single-donor primary hASC cultures. c) Quantification of ORO incorporated in HS-
expanded hASCs, normalized per cell number, at different times by spectrophotometric analysis. 
The average values ± SD of 3 independent experiments performed each in triplicate are reported. 
Real Time quantitative PCR analysis of pparγ2 (d) and c/ebpα (e) transcript levels in HS or FBS-
expanded hASCs at different times. The final results are expressed as means ± SD values 
considering 3 independent experiments assayed in triplicate. The *, ** and *** symbols refer to 
p≤0.0422, p=0.0065 and p=0.0009, respectively. Statistical analysis was performed using the 
unpaired t-Test. 
 
Figure 3: Adipogenic and osteogenic differentiation of HS-committed hASCs at P2 by using 
traditional differentiation protocols. a) Representative experiment assayed with ORO staining of 
adipogenesis-treated (ADIPO-INDUCED) and control (CTR) cells at the end of induction. The 
images on the right are magnification of the sections with dashed outline. Scale bar = 100 µm. The 
results were confirmed performing 3 independent experiments with different single-donor primary 
hASC cultures. b) Quantification of ORO incorporated in adipogenesis-treated (INDUCED) and 
control (CTR) cells at the end of induction by spectrophotometric analysis. The average values ± 
SD of 3 independent experiments performed each in triplicate are reported. c) Representative 
experiment assayed with ARS staining of osteogenesis-treated (OSTEO-INDUCED) and control 
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(CTR) cells at the end of induction. The lateral images with dashed outline are magnification of the 
treated and control cell layers. Scale bar = 100 µm. The results were confirmed performing 3 
independent experiments. 
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Figure 4: In vitro cultures of hASCs isolated and expanded in HS and stimulated with PL. a) Cell 
proliferation monitored at different times by cell counting. The average values ± SD of 3 
independent experiments performed in duplicate on different single-donor primary cultures are 
reported. The *** symbol corresponds to p=0.0004. Statistical analysis was performed using the 
unpaired t-Test. b) Cell viability evaluated at different times by MTT assay. The average values ± 
SD of 3 independent experiments performed each in triplicate are reported. c) Morphology of cells 
in HS (left photo) and in HS+PL (right photo) after 4-day treatment. Scale bar = 50 µm. d) The CFE 
assay performed on hASCs immediately after their isolation using complete medium supplemented 
with PL. Scans of dishes with methylene blue-stained colonies deriving from a representative 
experiment. e) Number of colonies per condition counted by naked eye. The average values ± SD 
are calculated referring to 5 independent experiments performed each in duplicate. f) ‘Colony area 
percentage’ and ‘colony intensity percentage’ calculated by ImageJ-plugin “ColonyArea” and 
referred to both tested condition. The average values ± SD are calculated referring to 5 independent 
experiments performed each in duplicate. The *** and **** symbols correspond to p=0.0001 and 
p<0.0001. Statistical analysis was performed using the unpaired t-Test. 
 
Figure 5: Modulation of proliferation-related pathways and activation of cell cycle in HS-expanded 
hASCs following multiple time intervals of PL stimulation investigated by western blot analysis. a) 
Representative western blot probed with primary antibodies raised against phospho-Akt, Akt, 
phospho-ERK1/2, ERK1/2, phospho-STAT3 and Actin. Actin was used as internal control. The 
results were confirmed performing 3 independent experiments with different single-donor primary 
hASC cultures. b) Densitometric analysis performed on 3 independent Cyclin D1-probed western 
blots (means ± SD) deriving from 3 different primary cell cultures (in the upper panel) and a 
representative western blot probed for Cyclin D1 and Actin (in the lower panel). Actin was used as 
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an internal control. The ** and *** symbols refer to p=0.0065 and p=0.0009, respectively. 
Statistical analysis was performed using the ordinary one-way ANOVA.  
 
Figure 6: PL effect on adipogenic differentiation of HS-expanded hASCs. a) Representative ORO 
staining of hASCs treated with complete medium supplemented with PL or un-supplemented for 4 
days. Scale bar = 25 µm. The results were confirmed performing 3 independent experiments with 
different single-donor primary hASC cultures. b) Quantification of ORO incorporated in HS-
expanded hASCs treated or not with PL for 4 days, which were normalized to the ratio between the 
cell number in PL-supplemented complete medium and the cell number in complete medium, by 
spectrophotometric analysis. The average values ± SD of 4 independent experiments performed 
each in triplicate on 3 different primary hASC cultures are reported. The * symbol refers to 
p=0.0230. Statistical analysis was performed using the unpaired t-Test. c) Real Time quantitative 
PCR analysis of pparγ2 transcript level in HS-expanded hASCs treated or not with PL for 4 days. 
The final results are expressed as means ± SD values considering 3 independent experiments 
assayed in triplicate. The ** symbol refers to p=0.0024. Statistical analysis was performed using the 
unpaired t-Test. 
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Figure 7: Adipogenic and osteogenic differentiation of hASCs further cultured with complete 
medium supplemented with PL for 3 passages by using traditional differentiation protocols. a) 
Representative experiment assayed with ORO staining of adipogenesis-treated (ADIPO-
INDUCED) and control (CTR) cells at the end of induction. The images on the right are 
magnification of the sections with dashed outline. Scale bar = 100 µm. The results were confirmed 
performing 3 independent experiments with different single-donor primary hASC cultures. b) 
Representative experiment assayed with ARS staining of osteogenesis-treated (OSTEO-INDUCED) 
and control (CTR) cells at the end of induction. The lateral images with dashed outline are 
magnification of the treated and control cell layers. Scale bar = 100 µm. The results were confirmed 
performing 3 independent experiments. 
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Figure 8: a) Effect of PL on HS-expanded hASC proliferation monitored in physiological and 
inflammatory by using crystal violet staining. For each culture condition, the n-fold increase of OD 
respect to day 0, expressed as the average of 3 independent experiments performed in quintuplicate 
on different single-donor primary cultures ± SD, was reported. b) The n-fold increase respect to day 
0 obtained at 4th treatment day for each culture condition. The * and ** symbols correspond to 
p=0.0445 and p=0.0024, respectively. Statistical analysis was performed using the ordinary one-
way ANOVA. 
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Figure 9: The PL effect on inflammatory response of HS-expanded hASCs under both 
physiological and inflammatory conditions. a) Secretion of IL-6 and IL-8 in hASC-conditioned 
media collected at 24, 48 and 72h after PL stimulation assayed by western blot. Densitometric 
analyses performed on 3 independent IL-6- or IL-8-probed western blots (means ± SD) deriving 
from 3 different single-donor primary cell cultures (in the upper panels) and representative western 
blots probed with primary antibodies raised against IL-6 and IL-8 (in the lower panels). The *** 
and **** symbols correspond to p=0.0002 and p<0.0001, respectively. Statistical analysis was 
performed using the ordinary one-way ANOVA. b) Representative western blots probed for COX-
2, mPGES-1 and Actin relative to hASC-cell lysates harvested at the end of PL stimulation and 
after 72h of serum-free incubation. Actin was used as internal control. The results were confirmed 
performing 3 independent experiments with different primary hASC cultures. c) Quantification of 
PGE2 in all conditioned media collected at 24h and in IL-1α- and PL+IL-1α-derived media 
collected at 72h by ELISA analysis. The averages of 3 independent experiments performed in 
duplicate on different primary cultures ± SD values were reported. The ** symbol refers to 
p≤0.0060. Statistical analysis was performed using the ordinary one-way ANOVA.  
 
Figure 10: Ex vivo culture of in toto hAT using complete medium supplemented with PL, IL-1α, or 
PL+IL-1α, or without any supplement, for 14 days. Cells released by hATs in all tested conditions 
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during the culture. Scale bar = 100 µm. The reported cell release was observed in 3 independent 
experiment performed on AT samples deriving from different patients. 
 
Figure 11: Histological analysis of in toto hAT samples cultured ex vivo using complete medium 
supplemented with PL, IL-1α, or PL+IL-1α, or without any supplement, for 14 days. a) 
Hematoxylin and Eosin (H&E) staining of paraffin-embedded hAT pieces at the end of the culture 
with each tested condition. The sample named ‘un-stimulated adipose tissue’ refers to hAT pieces 
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paraffin-embedded immediately after their isolation from the resection material and not cultured. b) 
Immunohistochemical analysis using a specific primary antibody raised against PCNA on paraffin-
embedded hAT pieces. Scale bar = 100 µm. 
 
Figure 1S: Osteogenic differentiation of HS-expanded hASCs by using a traditional differentiation 
protocol. Representative ORO staining of osteogenesis-induced (OSTEO-INDUCED, b) and 
control (CTR, a) cells at the end of induction at different magnifications. Scale bar = 100 µm. The 
results were confirmed performing 3 independent experiments with different single-donor primary 
cell cultures. 
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Figure 2S: Chondrogenic differentiation of HS-expanded hASCs by pellet-culture method under 
permissive conditions. Representative toluidine blue staining (a) and immunohistochemical analysis 
for type II collagen expression (b) of paraffin-embedded pellet at the end of induction. The images 
on the right are magnification of the sections with dashed outline. Scale bar = 200 µm. 
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Figure 3S: Osteogenic differentiation of hASCs further cultured with complete medium 
supplemented with PL for 3 passages by using a traditional differentiation protocol. Representative 
ORO staining of osteogenesis-induced (OSTEO-INDUCED, b) and control (CTR, a) cells at the 
end of induction at different magnifications. Scale bar = 100 µm. The results were confirmed 
performing 3 independent experiments with different single-donor primary cell cultures.
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4. CLOSING REMARKS 
My group of research previously investigated the activation of several cell systems in response to 
platelet lysate (PL) under both physiological and inflammatory conditions in order to elucidate the 
regenerative mechanisms taking place during wound-healing process. Considering that 
inflammation is the first body’s response to the injury and that platelet content triggers this 
response, they evaluated the in vitro effect of PL on inflammatory response of human keratinocytes, 
osteoblasts and chondrocytes demonstrating the rapid enhancement of the pro-inflammatory NF-κB 
pathway activity induced by IL-1α (El Backly et al., 2011; Pereira et al., 2013; Ruggiu et al., 2013). 
In association with such NF-κB pathway activation, they found the increased expression and 
secretion of pro-inflammatory cytokines IL-8 (in all investigated cell systems) and IL-6 (in 
osteoblasts and chondrocytes) and of antimicrobial lipocalin NGAL (in chondrocytes and 
keratinocytes) in presence of PL under inflammatory conditions. In osteoblasts, the induction of IL-
8 and IL-6 expression and secretion was transient as well as the expression and the production of 
pro-inflammatory COX-2 were temporarily induced by PL in inflammatory milieu. As a 
consequence of COX-2 activation, they found the strong production of PGE2, whose it is reported 
the capability of induce the functional switch of macrophages from pro-inflammatory M1 to pro-
resolving M2 phenotype (Maggini et al., 2010; Tasso et al., 2013a; Ulivi et al., 2014). It was also 
demonstrated that platelet rich plasma (PRP) was able to promote the differentiation of monocytes 
to a regulatory anti-inflammatory population producing the anti-inflammatory cytokine IL-10 and 
PGE2 (Papait et al., 2017). Overall, these findings suggest that platelet-released factors initially 
exert an immediate pro-inflammatory effect at the wound site and, at later time, an opposite effect 
by promoting the resolution of the inflammation phase. Considering the transient secretion of IL-8 
and IL-6 and the transitory activation of COX-2 in parallel with PGE2 secretion in presence of PL 
under inflammatory stimulus, the response of hASCs was consistent with the previous findings. 
Differently from the previous cell systems, HUVECs were instead protected by PL in the 
inflammatory milieu of the wound, because PL inhibited IL-1α-induced NF-κB activation already 
after 1-hour treatment and did not significantly enhance the production of IL-6 and IL-8 induced by 
IL-1α.  
One other important aspect in the tissue repair is the activation and the recruitment of resident 
progenitor cells. According to its own composition, it was reported that PL was able to induce a 
strong mitogenic response in the chondrocytes, which maintain a chondrogenic re-differentiation 
potential (Pereira et al., 2013), and in the osteoblasts without affecting their differentiation potential 
(Ruggiu et al., 2013). Moreover, Ruggiu et al., 2013 demonstrated that PL resumed the proliferation 
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of quiescent osteoblasts also with a burst of treatment (24 hour). In agreement with these outcomes, 
they showed the activation of proliferation-related Akt and ERK pathways, the induction of Cyclin 
D1 and the phosphorylation of retinoblastoma following PL stimulation. Similarly, HUVECs 
responded to PL with an increased proliferation rate maintaining their capability of forming tube-
like structures on matrigel and quiescent cells resumed proliferation showing the activation of Akt 
and ERK pathways and the induction of Cyclin D1 following PL treatment. In addition, PL induced 
also the stabilization of HIF-1α and the phosphorylation of STAT3, two factors involved in the 
angiogenesis, suggesting the possible in vivo contribution of PL to new vessel formation by 
activation of resident progenitor cells located in the vessel walls. In the adipose-tissue system, the 
mitogenic effect of PL was observed on hASCs that showed the activation of Akt, ERK and STAT3 
pathways and the induction of Cyclin D1 following PL treatment, and also in in toto adipose tissue 
cultured ex vivo corroborating the in vitro outcomes. Considering the behaviour of these different 
cell systems in the presence of PL, there are robust evidences regarding the mitogenic effect of PL 
on resident progenitor cells and possibly on resting differentiated cells in support to the 
reconstitution of damaged tissue structures. 
In the hASC study, I found that human serum (HS) was able to support cell proliferation much 
better than foetal bovine serum (FBS). However, hASCs expanded in HS showed the accumulation 
of lipid droplets and the up-regulation of two master regulators of adipogenesis, C/EBPα and 
PPARγ2, without adding any exogenous stimulus. Interestingly, these cells could be still 
differentiated towards the osteogenic lineage by using a traditional differentiation protocol. These 
findings suggest a hierarchy of progenitor cells within the hASC population expanded in HS with 
cells at different stages of commitment and differently responsive to the surrounding 
microenvironment. In this scenario, HS could exert a “niche” effect on hASCs regulating self-
renewal and differentiation of stem/progenitor cells included in this cell population in order to 
preserve a reservoir of immature cells.   
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5. CONGRESS PARTECIPATIONS And OTHER ACTIVITIES 
During my Ph.D. period, I participated in the following congresses: 
Congress Organization Date 
Poster 
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di Biologia e 
Genetica 
May 11th-13th, 2017 
Santa Margherita Ligure 
(IT) 
- - 
Advances in stem 
cells and regenerative 
medicine 
EMBO Conference 
May 23th-26th, 2017 
Heidelberg (DE) 
x - 
European Chapter 
Meeting of TERMIS 
2017 
TERMIS 
June 26th-30th, 2017 
Davos (CH) 
x - 
 
I also conducted the following activities: 
• Support work for the practical laboratory experiences relative to the following academic 
courses: 
	 82 
Course Academic Degree N° of hours Academic Year 
Biologia Cellulare e dello 
Sviluppo e Laboratorio di 
Colture Cellulari e di 
Biologia dello Sviluppo  
Corso di Laurea in 
Biotecnologie 
32 2014/2015 
Biologia Cellulare II e 
Laboratorio 
Corso di Laurea Magistrale in 
Biotecnologie Medico-
Farmaceutiche 
16 2015/2016 
Biologia Cellulare e dello 
Sviluppo e Laboratorio di 
Colture Cellulari e di 
Biologia dello Sviluppo  
Corso di Laurea in 
Biotecnologie 
32 2016/2017 
 
• Tutoring activity for students at undergraduate level (Laboratorio per il Medico in 
Formazione, Corso di Laurea in Medicina e Chirurgia, academic year 2016/2017); 
• Attendance at the basic course on “Animal Experimentation” organized by the S.S.D. 
Animal Facility of IRCCS Ospedale Policlinico San Martino in Genova, Italy (successfully 
completed); 
• Attendance at the online non-credit course “Basics of Extracellular Vesicles” authorized by 
University of California, Irvine and offered through Coursera (successfully completed). 
 
